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ABSTRACT
Effects of a Postpartum Sleep Schedule on Childless Women’s Sleep, Circadian
Amplitude, Daytime Sleepiness, Performance, and Mood
Amanda L. McBean, M.S.
OBJECTIVES: A complex process of physiological and environmental changes during
the postpartum period confounds our understanding of the discrete impacts of
postpartum sleep fragmentation. The aim of this dissertation was to isolate the effects of
postpartum sleep fragmentation by manipulating the sleep of childless women in the
laboratory to model a postpartum sleep fragmentation schedule. Actigraphically and
polysomnographically-recorded sleep, daytime functioning, mood, and melatonin
amplitude were quantified.
METHODS: Eleven healthy, childless women (25.4 [SD±2.3] years, 72.7% white,
$23,000 [SD±$11,000] household income) contributed continuous wrist actigraphy and
daily psychomotor vigilance test (PVT) for one baseline week followed by 3 consecutive
nights of overnight polysomnography: an adjustment/sleep disorder screening night, a
baseline night, and a night of experimental sleep fragmentation during which they were
awakened 3 times for 30-35mins each. During nocturnal awakenings, women engaged
in a standardized protocol that included feeding, changing, and rocking a doll in dim
light (<3 lux) to model postpartum motor activity and postures. First-morning baseline
and fragmentation night voids were collected for 6-sulphatoxymelatonin assays to
estimate circadian rhythm amplitude. Baseline and post-fragmentation Multiple Sleep
Latency Tests (MSLT) and Profile of Mood States Surveys (POMS) were administered.
A final week of at-home actigraphy monitoring, daily PVTs, and POMS captured
recovery.
RESULTS: Sleep time did not change between baseline (M=461±28min) and sleep
fragmentation nights (M=448±34min; p=.17), while sleep efficiency decreased
(M=90.9%±6.1%; M=74.4%±3.9%, respectively; p<.001). Frequency of PVT lapses
increased significantly from baseline (M=1.62±1.83) to the week after fragmentation
(M=2.72±1.76; p=.01). Mood disturbance increased from baseline (M=-1.00±7.10) to
after sleep fragmentation (M=8.55±12.9; p=.037). MSLT scores increased from baseline
(M=13.1±3.54) to after sleep fragmentation (M=16.3±3.51; p=.02), indicating decreased
daytime sleepiness. No changes in time spent in nocturnal sleep stages, 6sulphatoxymelatonin concentration and actigraphy-defined total sleep time were found
after sleep fragmentation compared to baseline.
CONCLUSIONS: The current study is the first to experimentally examine the effects of a
simulated postpartum sleep disturbance schedule on aspects of physiology and
behavior. Results suggest no changes in measured physiological components of a
single night of simulated postpartum sleep fragmentation, but significant deficits in mood
and neurobehavioral performance. Disruption of sleep continuity in the absence of
measured physiological changes may be sufficient to cause poorer mood and
performance.

SUPPORT: WVU Office of Academic Affairs Doctoral Student Research Support (AM);
WVU Alumni Fund (AM); WVU Behavioral and Biomedical Sciences Training
Scholarship Research Award (AM)
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Legend
AANAT = arylkylamine N-acetyltransferase
AASM = American Academy of Sleep Medicine
ANOVA = Analysis of Variance
aMT6 = 6-sulphatoxymelatonin
EDS = Excessive Daytime Sleepiness
ELISA = Enzyme-linked Immunosorbent Assay
M-E = Morningness-Eveningness
MSLT = Multiple Sleep Latency Test
PLMA = Periodic Limb Movements with associated Arousals
PLMS = Periodic Limb Movements in Sleep
PMDD = Premenstrual Dysphoric Disorder
POMS = Profile of Mood States Survey
PSG = Polysomnography
PVT = Psychomotor Vigilance Test
TMD = Total Mood Disturbance
TNF-α = Tumor Necrosis Factor Alpha
TST = Total Sleep Time
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Effects of a Postpartum Sleep Schedule on Childless Women’s Sleep, Circadian
Amplitude, Daytime Sleepiness, Performance, and Mood
Introduction
The maternal postpartum period is characterized by sleep fragmentation, which
is associated with daytime impairment, mental health disturbances, and changes in
melatonin levels. While sleep fragmentation can cause each of these outcomes, new
mothers vary in the severity to which they experience these outcomes. These individual
differences are likely a result of a complex process of individual physiological and
environmental differences, so the relative contribution of sleep fragmentation to each of
these outcomes is unknown. The purpose of this study was to understand the basic
impact of sleep fragmentation, common during the maternal postpartum period, on
sleep architecture, nocturnal melatonin, mood, daytime sleepiness, performance, and
recovery. This was done by applying a maternal postpartum sleep schedule to healthy
childless women, and modeling postpartum nocturnal activities such as light exposure,
posture, and movement. The innovative component of the study that is expected to
contribute to the advancement of our understanding and interventions was studying
childless adult women in the sleep laboratory. This allowed for isolation of the specific
effects of a single night of sleep fragmentation from postpartum physiological and
environmental changes, while controlling for nocturnal activities, light levels, and
postural changes; such stringent control is difficult to logistically and ethically use
among a true postpartum population.
The study protocol (diagrammed in Figure 1 below for a single participant) was
used to monitor each of 11 childless women’s sleep and performance at home for one
week before she came into the sleep laboratory for an assessment of daytime
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sleepiness, followed by three consecutive nights in the laboratory. The first night served
as both an adjustment night to the sleep laboratory and as a screening for sleep
disorders; the second night was used as a measure of baseline sleep; the third night
was the experimental sleep fragmentation night. After the baseline and experimental
sleep fragmentation nights, morning urine samples were collected to estimate nocturnal
melatonin levels. Another assessment of daytime sleepiness occurred the day
proceeding the experimental sleep fragmentation night, followed by a week of at-home
monitored sleep and daily performance assessments and every-other-day mood
surveys to quantify recovery.
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Figure 1. Study protocol for a single participant
Day

Time of Day
22 23 24

1

2

3

4

5

6

7

8

9

1

Actigraphy*

PVT*

2

Actigraphy*

PVT*

3

Actigraphy*

PVT*

4

Actigraphy*

PVT*

5

Actigraphy*

PVT*

6

Actigraphy*

PVT*

7

Actigraphy*

PVT*

8

S^

14 15 16 17

18 19 20 21 22

MSLT*/POMS*

S*

9
10

10 11 12 13

M*
S

S

S

S

MSLT/POMS

M

11

Actigraphy

PVT

12

Actigraphy

PVT

13

Actigraphy

PVT

14

Actigraphy

PVT

15

Actigraphy

PVT

16

Actigraphy

PVT

17

Actigraphy

PVT

POMS

POMS

POMS

*Baseline Assessments
^Lab adjustment and sleep disorder screening night for participant (data not used)
Actigraphy=At home sleep with fixed bed times (10pm-12pm) and rise times (6am-8am)
PVT=Psychomotor Vigilance Test (performance assessment)
MSLT=Multiple Sleep Latency Test (in lab daytime sleepiness assessment)
POMS=Profile of Mood States survey
S=In lab sleep periods recorded using polysomnography
M=Urine 6-sulphatoxymelatonin samples (overnight & first morning void)
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To provide a context for the current study, the introduction is split into two major
sections. The first section provides a background on normative sleep and maternal
postpartum sleep fragmentation. The second section focuses on the effects of sleep
disturbance on the circadian system of the sleep-wake cycle, sleep architecture,
daytime sleepiness, mood, and recovery.
Sleep and Postpartum Sleep Disturbances
Normal Sleep
Sleep occurs in cycles, each cycle lasting about 70-120 minutes (Kryger, Roth, &
Dement, 2011). The human sleep cycle begins with three stages of non-Rapid Eye
Movement (NREM) sleep (stages N1, N2, and N3), then transitions into REM sleep. If
the sleep cycle is interrupted at any point, it must start from the beginning. While a
thorough understanding of the function of these components remains largely unknown,
particular attention and importance has been placed on REM sleep and stage N3 sleep,
the deepest stage of NREM sleep characterized by delta EEG waves. There is support
for a role of stage N3 in the restorative aspect of sleep, as specific disruption to stage
N3 leads to increased daytime sleep propensity (Dijk, Groeger, Stanley, & Deacon,
2010). REM sleep likely plays a role in cognitive functioning, especially the
consolidation of new memories (for review see McCoy & Strecker, 2011).
Sleep Fragmentation
Sleep fragmentation is a type of sleep disturbance in which there is a disruption
in sleep continuity. This differs from sleep deprivation (a reduction in total sleep time) in
that the quality of sleep is compromised, not the quantity. Existing research indicates
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both sleep deprivation and sleep fragmentation yield similar adverse health
consequences. Experimentally induced sleep fragmentation among healthy adults
causes poorer mood (Bonnet, 1985), impaired daytime functioning (Bonnet, 1985;
Durmer & Dinges, 2005; Zaharna & Guilleminault, 2010), hormonal alterations (Zaharna
& Guilleminault, 2010), and daytime fatigue (Zaharna & Guilleminault, 2010)
comparable to the impact of sleep deprivation. Moreover, as sleep deprivation alters the
concentration of nocturnal melatonin (a biomarker of the central circadian clock)
(Cajochen, Jewett, & Dijk, 2003; Kavčič et al, 2011), sleep fragmentation may also
disrupt the concentration of melatonin. These specific effects of sleep disturbances will
be presented in more detail in the following sections. Yet the protocol of experimental
sleep fragmentation used in these studies differs from the fragmentation among
postpartum mothers, who experience much longer periods of consolidated sleep, but
also longer periods of wakefulness. The effects of postpartum sleep fragmentation are
not fully understood.
Postpartum Sleep Disturbances
Postpartum mothers experience sleep disturbances, characterized by sleep
fragmentation, during the early postpartum period (Gay, Lee, & Lee, 2004; Hunter,
Pychnovsky, & Yount, 2009; Montgomery-Downs, Insana, Clegg-Kraynok, & Mancini,
2010). At postpartum week 2, new mothers obtain approximately 7.2 hours of total sleep
time, despite spending about 9 hours in bed (Montgomery-Downs et al., 2010). Thus,
they experience reduced sleep efficiency and increases in wake after sleep onset (Gay
et al., 2004; Matsumoto, Shinkoda, Kang, Seo, 2003).
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Mechanisms for Postpartum Sleep Disturbances
Infant Sleep
Postpartum maternal sleep is interrupted by frequent infant nocturnal awakenings
(Santiago, Nolledo, Kinzler, & Santiago, 2001). Infants are not born with a sleep-wake
rhythm that promotes one consolidated nocturnal sleep period. Instead they exhibit
polyphasic sleep, whereby they have multiple sleep periods across a 24-hour period. A
stable sleep-wake rhythm in infants develops over time, as sleep periods gradually
lengthen so that most infants can “sleep through the night” about three months after
birth (de Weerd & van den Bossche, 2003; Kleitman & Engelmann, 1953). These
frequent infant nocturnal awakenings have implications for maternal sleep as there are
strong correlations between maternal nocturnal awakenings and infant movements
indicative of wake (Nishihara, Horiuchi, Eto, & Uchida, 2002; Wulff & Siegmund, 2000).
Postpartum Physiological Changes
New mothers experience physiological changes throughout pregnancy and the
postpartum period that may be impacting their sleep and mental health above and
beyond the nocturnal infant demands. Steroid hormones such as estrogen,
progesterone, and cortisol increase during pregnancy and abruptly decrease after
parturition (Bonnar, Franklin, Nott, & McNeilly, 1975; Tulchinsky, Hobel, Yeager, &
Marshall, 1972; West & McNeilly, 1979); this abrupt transition has posited to be
associated with mood disturbances (Bloch et al., 2000; Bloch et al., 2005; Doornbos et
al., 2009). Estrogen and progesterone have sleep-promoting effects (Ross, Murray, &
Steiner, 2005). Estrogen decreases sleep onset latency, nocturnal awakenings and
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REM sleep, while increasing total sleep time. Progesterone is sedative, decreasing
wakefulness and latency to NREM sleep as well as decreasing REM sleep. High cortisol
levels are associated with stress and depressive symptoms (Manber & Armitage, 1999).
Mothers who choose to breastfeed may be further altering their sleep and their
infant’s sleep in unique ways from formula feeding mothers. Breastfeeding may have a
soporific effect on infants as a result of the rise of 4 nucleotides present in breast milk
that have circadian rhythms (Sánchez et al., 2009). Prolactin levels, which rise
throughout pregnancy, return to pregravid levels in a few weeks among non-lactating
women. However, breastfeeding induces the release of oxytocin, a hormone that
stimulates pituitary lactotrophic cells and preserves high prolactin levels, which in turn is
strongly associated with sleep (Sassin, Frantz, Weitzman, & Kapen, 1972). Therefore,
hormonal changes postpartum may be further altering sleep and mental health, and
perhaps their impact may even be protective of maternal sleep.
Physiological changes during the postpartum period that may impact sleep and
mental health are not limited to hormonal changes. Most new mothers complain of at
least one physical health symptom during the early postpartum period (Ansara, Cohen,
Gallop, Kung, & Schei, 2005). The most commonly reported symptoms include general
pain, headaches, fatigue, backaches, abdominal pain, bowel incontinence, and breast
soreness (Cheng & Li, 2008; Webb et al., 2008). While there is a lack of literature
specifically on postpartum physical pain and sleep, more than half of adults with chronic
pain also experience sleep disturbances (Marty et al., 2008; McCracken & Iverson,
2002; Rohrbeck, Jordan, & Croft, 2007). Further, postpartum physical health conditions
are associated with emotional well-being and depressive symptoms (Webb et al., 2008),
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which is bidirectionally associated with sleep (Dørheim, Bondevik, Eberhard-Gran, &
Bjorvatn, 2009; McCoy, 2011; Posmontier, 2008; Ross et al., 2005).
Postpartum Environmental Changes
The postpartum period is also characterized by adjustment to a new parenting
role that includes caring for an infant and coping with the resultant emotional and social
change (Brage Hudson, Elek, & Fleck, 2001). Child-care responsibilities and lack of
knowledge related to parenting can be sources of frustration and fatigue for new
mothers (Kanotra et al., 2007). Postpartum fatigue is indirectly associated with stress
via depressive symptoms and sleep quality (Groër et al., 2005; Song, Change, Park,
Kim, & Nam, 2010). New mothers may vary substantially in their adjustment to the
postpartum period as a result of available social support. New mothers report social
networks as their primary source of support (Leahy-Warren, 2007), and social support is
a recognized buffer for stressful life events and predictor of emotional and physical wellbeing (Hung, 2004). Thus, the impact of the postpartum period on sleep and mental
health is not limited to physiological changes, but also includes the environment.
Effects of Sleep Disturbance
Circadian Rhythm
An established model of sleep postulates that sleep and wake are regulated by
two fundamental processes: a homeostatic sleep drive (Process S) and a circadian
timing system (Process C) (Borbély, 1982). The homeostatic process regulates sleep
propensity on the basis of prior wake time. The circadian system governs the timing of
nearly all 24-hour endogenous biological processes within the body, including sleep and
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wake. These two processes interact such that as sleep drive accumulates across the
waking day, an increasing circadian wake drive compensates for the buildup of
sleepiness and results in a relatively steady level of wakefulness across the day. As the
need for sleep dissipates in the first few hours of nocturnal sleep, an increase in
circadian sleep drive during the second half of the night allows sleep to continue (Dijk &
von Schantz, 2005). When these processes are not in harmony, mood, daytime
functioning, and physical health may be impaired (Mendlewicz, 2009; Mosendane,
Mosendane, & Raal, 2008; Reid & Zee, 2009).
The circadian system is controlled by a central circadian pacemaker in the
suprachiasmatic nuclei (SCN) of the hypothalamus (Eastman, Mistleberger, &
Rachtschaffen, 1984; Ralph, Foster, Davis, & Menaker, 1990). The SCN are paired
nuclei, each containing approximately 10,000 small, highly dense neurons. Individual
neurons within the SCN are capable of producing circadian oscillations, which
synchronize remarkably to generate coordinated outputs that regulate overt rhythms.
These oscillatory rhythms are self-sustaining in conditions absent of time cues
(zeitgebers) and are regulated by a network of transcriptional-translational feedback
loops (Reppert & Weaver, 2001).
The period of these rhythms is not exactly 24-hours, and under conditions in
which there are no time cues, the rhythms will drift slightly each day (Czeisler, et al.,
1999; Duffy et al., 2011). Most adults have a period longer than 24 hours - the average
circadian period is approximately 24 hours 9 minutes in length. However, about 35% of
females and 14% of males have circadian periods shorter than 24 hours (Duffy et al.,
2011). Under typical conditions, the circadian rhythm is reset on a daily basis by
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zeitgebers, which allows the circadian rhythm to maintain a periodicity that matches the
24-hour solar day (Pittendrigh & Daan, 1976). The circadian rhythm is most vulnerable
to time cues when they are not expected to be present, such as light exposure during
the subjective night (Roenneberg, Daan, & Merrow, 2003). The restorative benefits of
sleep are most pronounced when sleep occurs during the typical sleep hours shaped by
an individual’s circadian rhythm (Gillette & Abbott, 2005).
Melatonin serves as a biomarker for the circadian rhythm and is measurable in
humans in plasma, saliva, and urine through its urinary metabolite, 6sulphatoxymelatonin (aMT6) (Benloucif et al., 2008). Melatonin is an indole hormone
secreted by the pineal gland with a robust circadian rhythm: concentrations of melatonin
are stable and very low during the day, with an abrupt rise a couple hours before
habitual bedtime, peaking overnight, and decreasing to the low daytime level close to
habitual rise time. Melatonin is synthesized from serotonin primarily in the pineal gland.
Daytime levels of serotonin are high, but decrease at night in the presence of melatonin
formation due to its consumption by this process. Arylkylamine N-acetyltransferase
(AANAT), a critical enzyme in the conversion of serotonin to melatonin, is considered
the rate-limiting factor in the production of melatonin. AANAT follows a circadian rhythm
of low activity during the day, limiting daytime production of melatonin (for review see
Borjigin, Zhang, & Calinescu, 2012; Ganguly, Coon, & Klein, 2002). The activity of
AANAT is regulated by the suprachiasmatic nuclei (SCN) of the hypothalamus, the site
of the central circadian pacemaker.
Postpartum women experience a disruption in their circadian rhythm (Matsumoto
et al., 2003; Nishihara et al, 2002; Thomas & Burr, 2006; Wulff & Siegmund, 2000).
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Thus far, the postpartum circadian rhythm has primarily been characterized by a blunted
pattern of nocturnal levels of melatonin compared to nulliparous controls (Thomas &
Burr, 2006) and pregnancy levels (Wierrani, Hlawka, Kroiss, Grünberger, 1997). These
altered melatonin levels may be associated with postpartum mood disorders such as
depression (Anderson, 2010; Parry et al., 2008). However, the cause of the altered
postpartum circadian rhythm is not known.
Changes in hormones during the postpartum period may cause disruption of the
circadian rhythm. During pregnancy, estradiol and progesterone levels were inversely
related to melatonin (Pang et al., 1987). While no human studies relate prolactin,
oxytocin, and melatonin postpartum, a study in early postpartum ewes found prolactin
levels were inversely related to melatonin (Molik, Misztal, Romanowicz, Zieba, 2010)
In addition, sleep disturbances may influence melatonin levels. The impact of
total sleep deprivation on melatonin varies across studies. Total sleep deprivation
combined with continuous 50 lux light exposure and sedentary activity (regularly seated)
overnight reduced overall nocturnal melatonin production compared to normal sleep
nights (Kavčič et al, 2011). Conversely, another study among young adult males found
no effect of sleep deprivation on nocturnal melatonin levels (von Truer, Norman, &
Armstrong, 1996). These studies did not address sleep fragmentation, which would
relate to postpartum women. Yet, similar contradictory evidence exists regarding the
impact of sleep fragmentation, as seen in patients with obstructive sleep apnea (OSA),
on nocturnal melatonin levels. Wikner et al. (1997) studied males with OSA before and
after treatment, and healthy control males. Melatonin did not differ before and after
treatment of OSA, nor did the melatonin levels in OSA patients differ from healthy
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controls. Conversely, Hernández et al. (2007) found that patients with OSA did not have
a nocturnal melatonin peak, but healthy controls did.
The distinction between postpartum sleep disturbance and hormonal changes on
melatonin patterns has not been made. The current study manipulated the sleep of
childless women using a postpartum-like schedule in order to isolate the impact of
postpartum sleep disturbance on a major metabolite of melatonin, aMT6.
Sleep Architecture
Sleep fragmentation can impact the amount of time spent in specific sleep
stages. Among healthy adults who were awakened by an audiometer every minute
throughout the sleep period (and verbally confirmed each awakening), the percentage
of time spent in stages N2, N3, and REM sleep was significantly decreased, while the
time spent in stage N1 sleep was increased compared to a baseline night (Bonnet,
1985). Total sleep time on the sleep fragmentation night was only one hour less than
the total sleep time on the baseline night. Similarly, another study that experimentally
induced sleep fragmentation among healthy adults by playing auditory tones at on
average every 2 minutes caused a change in the amount of time spent in specific sleep
stages while preserving total sleep time. During the fragmentation night time spent in
stage N3 and REM were significantly reduced, and time spent in stages N1 and N2
were significantly increased compared to the screening night (Roerhs et al., 1994).
There is still limited research about time spent in certain sleep stages
postpartum. While one study found postpartum women spend significantly more time in
stage N3 and less time in REM than during pregnancy (Driver & Shapiro, 1992), another
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study suggested no differences in sleep stages between pregnancy and postpartum
(Nishihara & Horiuchi, 1998). The most recent study compared postpartum women to
childless controls and found postpartum women spent a greater percentage of time in
stage N3 than controls (Nishihara et al., 2004). These authors suggest that this increase
was more likely to be explained by the release of prolactin secretion promoted by
breast-feeding than the rebound effect of sleep disturbance because there was no
change in the time spent in stage N3 among women at postpartum weeks 9-13 on
uninterrupted nights of sleep versus nights when they awoke for infant caregiving.
Therefore, the current study aimed to characterize sleep architecture as a result of the
sleep fragmentation experienced by women during the early postpartum period, without
the mitigating effects of hormonal changes by using a sample of childless, adult women.
Daytime Sleepiness
Excessive daytime sleepiness (EDS) is a common consequence of sleep
disturbance and refers to an increased propensity to fall asleep and suffer sleep attacks
when sleep is not desired (Benbadis, 2005). EDS can have devastating consequences
including decreased performance, diminished intellectual capacity, and increased risk
for vehicular and industrial accidents (Carskadon & Dement, 1987; Philip et al., 2010).
Daytime sleepiness has been the primary recognized cause for many high profile
disasters, including Three Mile Island, Chernobyl, Challenger explosion, and Exxon
Valdez (Walsh, Dement, & Dinges, 2005). Of particular concern, perception of
sleepiness is not a reliable indicator of sleep onset in monotonous situations,
suggesting people are not reliable judges of their own propensity to fall asleep during
inappropriate times (Herrmann et al., 2010).
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Sleep disorders commonly associated with EDS include sleep insufficiency,
sleep apnea, narcolepsy, idiopathic hypersomnia, and periodic limb movement
disorders (Benbadis, 2005). Sleep apnea and periodic limb movement disorders are
both disorders characterized by sleep fragmentation, supporting the notion that sleep
fragmentation can result in daytime sleepiness. In the laboratory, when experimental
sleep fragmentation was produced among healthy adults by the presentation of auditory
tones at approximately 2-minute intervals, objective levels of daytime sleepiness were
increased (Roehrs et al, 1994).
The mechanism through which sleep fragmentation causes daytime sleepiness,
while preserving total sleep time, is not yet understood. Recent lines of evidence
suggest roles for the activation of specific cytokines in mediating the relation between
sleep fragmentation and daytime sleepiness. Tumor necrosis factor alpha (TNF-α) is
involved in the pathogenesis of many chronic inflammatory diseases and immune
responses (Popa, Netea, can Riel, can der Meer, Stalenhoef,, 2007; Zhang et al.,
2009). Cytokines such as TNF-α also have established roles in the regulation of sleep.
Administration of exogenous TNF-α induces sleepiness and produces excessive sleep
whereas inhibition of TNF-α decreases the onset of spontaneous sleep (for review see
Krueger, 2008). Mice lacking the TNF-α receptor did not show cognitive dysfunction or
changes in biomarkers of sleep propensity (Kaushal, Ramesh, & Gozal, 2012; Ramesh
et al., 2012) after chronic experimental sleep fragmentation, in contrast to control mice.
Total sleep time and sleep architecture was preserved during the sleep fragmentation
protocol (Kaushal et al., 2012), suggesting the TNF-α pathway works independently of
these variables.
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Adenosine, an inhibitory neuromodulator, may also serve as a potential mediator
between sleep fragmentation and daytime sleepiness. Experimental systemic and
intracerebral injection of adenosine has increased sleep (Benington, Kodali, & Heller,
1995; Portas, Thakkar, Rainnie, Greene, & McCarley, 1997), whereas adenosine
antagonists (ex. caffeine) increase arousal (Fredholm, Battig, Holmén, Nehlig, &
Zvartau, 1999). Adenosine may facilitate sleep through the inhibition of neurons related
to arousal in the basal forebrain (Porkka-Heiskanen et al., 1997). Levels of adenosine
have been shown to rise in the basal forebrain during sleep deprivation (PorkkaHeiskanen et al., 1997; Porkka-Heiskanen, Strecker, & McCarley, 2000) as well as
during sleep fragmentation (McKenna et al., 2007). However, the role of cytokines and
adenosine in the mediating the relation between sleep fragmentation and daytime
sleepiness is still unclear. Cytokines and adenosine may be driving the effects of sleep
disturbance, providing a compensatory response, or providing an additional unknown
function.
Postpartum mothers, who are an otherwise healthy population without preexisting sleep disorders, experience both a unique form of fragmented sleep that differs
from the sleep fragmenting disorders, but appear to experience similar consequences.
Postpartum mothers experience impaired neurobehavioral performance throughout the
first 12 postpartum weeks compared to childless controls (Insana & MontgomeryDowns, 2013). At 6-weeks postpartum, mothers fall asleep on a Multiple Sleep Latency
Test (MSLT) (an objective measure of daytime sleepiness) in an average of 11.8
minutes, a time that is borderline moderate daytime sleepiness that may or may not be
at pathological levels (Insana & Montgomery-Downs, 2012). Furthermore, there are
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large individual differences in the daytime sleepiness values – the standard deviation for
these women was 4.6 minutes with a range of 3.1-18.6 minutes. What is unclear is how
much of this variation has to do with the actual sleep disturbances experienced versus
physiological (e.g. postpartum physical and hormonal changes) and environmental
factors (e.g. life changes associated with caring for an infant). The current study
attempted to control the environmental factors that could be influencing sleepiness, and
used a non-postpartum sample to control for the physiological changes characterizing
this period, to provide a clearer understanding of how sleep fragmentation during the
early postpartum period impacts daytime sleepiness and performance.
Mood
Both sleep deprivation and sleep fragmentation can have negative effects on
mood. One week of experimental chronic restriction of sleep to 4-5 hours per night
resulted in worsened mood as reported on the Profile of Mood States (POMS) total
mood disturbance, and subscales of fatigue, vigor, confusion, and tension (Dinges et al,
1997). Similar mood disturbances are seen after experimental sleep fragmentation; two
nights of consecutive sleep fragmentation caused by awakenings from an auditory tone
every minute throughout the nights degraded mood to levels that were greater than a
single night of total sleep deprivation, despite obtaining over 5 hours of total sleep time
each night (Bonnet, 1985).
Postpartum mood disturbances are prevalent; 85% of mothers report transient
changes in mood during the first postpartum week (Ross et al., 2005), and an estimated
7-17% of women are diagnosed with postpartum depression after the fourth postpartum
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week (Figueiredo & Conde, 2011; Horowitz, Murphy, Gregory, Wojcik, 2009; Milgrom et
al., 2008; Ross et al., 2005; Pearlstein, Howard, Salisbury, Zlotnick, 2009). The adverse
outcomes of postpartum depression affect the entire family unit and include: disruption
in the marriage, increased neglect in child caregiving, delayed child development, and a
poorer mother-infant relationship (Field, 2010; McCoy, 2011; Righetti-Veltema, ConnePerreard, Bousquet, & Manzano, 2002). In many cases, a diagnosis of postpartum
depression triggers recurring or chronic episodes of depression throughout the woman’s
life (Cooper & Murray, 1995; Goodman, 2004).
Yet the etiology of postpartum mood disturbances is a complex system that is not
clearly understood. While the literature explained above suggests a role for sleep
disturbance in causing mood disruptions postpartum, evidence also supports
physiological and social causes of mood disruptions. Postpartum women experience
marked changes in concentrations of sex steroids after birth, which could provide a
possible mechanism for mood disruptions (for review see Russell, Douglas, & Ingram,
2000). Moreover, postpartum mood disruption could be caused by social factors, such
as low levels of social support or the recent experience of a stressful event (Robertson,
Grace, Wallington, & Stewart, 2004). Postpartum mood disturbances likely do not have
a single cause, but rather are a combination of exposure to multiple risk factors. The
current study examined the role of a single night of postpartum-like sleep disturbance
on mood.
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Recovery from Sleep Disturbance
The trajectory of recovery after sleep disturbance is not well elucidated.
Neurobehavioral deficits caused by 5 consecutive nights of 4 hours of time in bed
improved in a dose-response relation with increasing time in bed on a subsequent
recovery night. However, even after 10 hours in bed after the imposed sleep restriction,
neurobehavioral deficits remained, suggesting either a longer sleep period or multiple
nights are required to return to baseline levels of performance (Banks, Van Dongen,
Maislin, & Dinges, 2010).
Moreover, the average postpartum woman experiences chronic sleep
fragmentation until their infant has developed a consolidated sleep-wake schedule that
allows for sleeping through the night, which occurs around the age of three months
(Kleitman & Engelmann, 1953; de Weerd & van den Bossche, 2003). Yet when, or even
if, a woman recovers from this sleep disturbance is unknown. Preliminary data from our
lab indicate mothers with one child between the ages of 6-30 months old did not differ in
objective daytime sleepiness from mothers with one 6-week old child, despite the fact
their sleep had normalized to the level of controls. The current study provided basic
information concerning the impact of a single night of postpartum-like sleep disturbance
on total sleep time, neurocognitive performance, and mood for a week following the
sleep disturbance.
Statement of the Problem
The purpose of the current study was to understand the basic effects of a single
night of sleep fragmentation, as seen during the maternal early postpartum period, on
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nocturnal sleep stages, daytime impairment and recovery, mood, and melatonin levels.
Only one night of sleep fragmentation occurred in the current study because of interest
in the effects of acute sleep fragmentation, Multiple nights of sleep disturbance would
begin to capture a different phenomenon, recovery sleep, whereby any alterations in
sleep architecture on the first sleep disturbance night impact sleep architecture
differently on subsequent nights (e.g. REM rebound, or increases in REM sleep)
(Kilduff, Kushida, & Terao, 2005; Roehrs et al., 2004). Understanding the impact of
acute postpartum sleep fragmentation, and whether there are even changes to sleep
architecture on just one night, was the goal of the current study; examining multiple
nights captures a different phenomenon that was beyond the scope of the current study.
New mothers experience sleep fragmentation that is associated with daytime
impairment, mental health disturbances, and blunted levels of melatonin. However,
there have also been large individual differences reported on each of these measures
among new mothers. These individual differences are likely a result of individual
physiological and environmental differences. No study has yet controlled for the
physiological and environmental factors that could be impacting some of these
outcomes, likely due to the difficulties of studying this population in a laboratory and the
logistic and ethical barriers to changing and manipulating their routine. This study
attempted to overcome these barriers and provide a basic understanding of the effects
of a night of postpartum-like sleep fragmentation by manipulating the sleep of healthy,
adult women without children to resemble what is observed during the early postpartum
period. This study design allowed for the isolation of the postpartum-like sleep
disturbances effects, without the confounding physical, hormonal, or social changes as
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a result of giving birth, helping further understand the specific role of the sleep
disturbance on specified outcomes.
Further, it is expected that data from the current study will provide a foundation
for future studies in which environmental changes such as nocturnal light exposure,
posture, and activities performed simultaneously to infant feeding/caregiving, can be
systematically manipulated to determine their individual contributions to sleep and
related outcomes. It also provides a basis for future studies of the role postpartum
hormonal changes have on sleep, daytime sleepiness, performance, and mood.
Understanding the relative importance of these factors to sleep-related outcomes is
expected to guide postpartum interventions.
Research Questions and Hypotheses
RQ#1: How does a single night of experimentally-simulated postpartum sleep
disturbance affect nocturnal melatonin release among healthy nulliparous
women?
H1: One night of postpartum-like sleep disturbance will cause a suppression of 6sulphatoxymelatonin compared to the baseline night.
This hypothesis was based on the blunted nocturnal levels of melatonin that have been
described among postpartum women (Thomas & Burr, 2006). Other support for this
hypothesis can be found in some studies that showed decreased total nocturnal levels
of melatonin after experimental sleep deprivation (Kavčič et al., 2011) and absence of a
nocturnal melatonin peak among patients with obstructive sleep apnea, a sleep disorder
characterized by sleep fragmentation (Hernandez et al., 2007). Among patients with
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Alzheimer’s Disease (AD), a decreased amplitude of the melatonin rhythm has been
hypothesized to explain the irregular sleep-wake rhythm and fragmented sleep
symptoms (for review, see Sack et al., 2007).
RQ#2: How does a single night of experimentally-simulated postpartum sleep
disturbance affect sleep architecture among healthy nulliparous women?
H2a: Percentage of time spent in stage N1 sleep will be increased in the
experimental night compared to the baseline night.
H2b: Percentage of time spent in stage N2 sleep will be increased in the
experimental night compared to the baseline night.
H2c: Percentage of time spent in stage N3 sleep will be reduced in the
experimental night compared to the baseline night.
H2d: Percentage of time spent in REM sleep will be reduced in the experimental
night compared to the baseline night.
Each time there is a disruption in the sleep cycle (such as an awakening), the sleep
cycle must begin from the beginning - you cannot pick up in the sleep stage you left off
in prior to the awakening. Thus, multiple awakenings from sleep fragmentation would
theoretically lead to more time spent in stages at the beginning of the sleep cycle (N1
and N2) and less time spent in stages at the end of the sleep cycle (N3 and REM).
Experimental sleep fragmentation studies support this, showing significant increases in
time spent in stage N1 sleep, and decreases in time spent in stages N3 and REM sleep
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(Bonnet, 1985; Roehrs et al., 1994). However, stage N2 sleep was increased in one
study (Bonnet, 1985) and decreased in another (Roehrs et al., 1994).
RQ#3: How does a single night of experimentally-simulated postpartum sleep
disturbance impact daytime sleepiness among healthy nulliparous women?
H3: One night of experimental sleep disturbance will cause greater daytime
sleepiness on a Multiple Sleep Latency Test than baseline night.
This hypothesis was based on widespread evidence that sleep disturbance results in
daytime sleepiness (Benbadis, 2005). Sleep disorders characterized by sleep
fragmentation cause excessive daytime sleepiness (Benbadis, 2005); postpartum
women, who also experience fragmented sleep, demonstrate daytime sleepiness
(Insana & Montgomery-Downs, 2012). Finally, experimental sleep fragmentation causes
increased levels of daytime sleepiness (Roehrs et al., 1994).
RQ#4: How does a single night of experimentally-simulated postpartum sleep
disturbance impact the next week’s sleep, performance, and mood among healthy
nulliparous women?
H4a: Experimental sleep disruption will cause increased actigraphy-measured
total sleep time on the proceeding at-home recovery night, compared to baseline
at-home total sleep time, and total sleep time will decrease to baseline levels
after the first recovery night.
This hypothesis was based on the 10-20% increase in total sleep time the night
following partial and total sleep deprivation (Benoit et al., 1980; Webb & Agnew, 1975).
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The night directly following experimental sleep fragmentation also had a greater total
sleep time; however, this was not significant (Bonnet, 1985).
H4b: Experimental sleep disruption will cause worse performance on a
psychomotor vigilance test (PVT) on the morning after experimental sleep
fragmentation compared to baseline condition, and will gradually improve to
baseline levels across the recovery week.
This hypothesis was based on the worsening performance seen after sleep disruption,
and that after one night of recovery sleep, performance levels are still significantly
worse than controls (Banks et al., 2010; Sallinen et al., 2008). This suggests multiple
recovery nights are necessary for performance to return to baseline, but the number of
nights necessary is not yet clear.
H4c: Experimental sleep disruption will cause higher POMS total mood
disturbance scores the day after experimental sleep fragmentation compared to
baseline condition, and will gradually improve to baseline levels across the
recovery week.
This hypothesis was based on research that indicates sleep disturbance can impair
mood (Bonnet, 2005). One night of sleep deprivation decreased mood, and took 2
recovery nights to return to baseline (Ikegami et al., 2009). Acute experimental sleep
fragmentation decreased mood among healthy adults (Bonnet, 1985; Martin, Engleman,
Deary, & Douglas, 1996). Among women within the first postpartum week, the amount
of sleep lost at night was directly associated with worse mood (Swain, O’Hara, Starr, &
Gorman,1997).
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Supplemental Analyses: If any of the hypotheses concerning the worsening of mood,
PVT performance, or MSLT scores were supported, supplemental analyses comparing
these results to existing data from postpartum women in the lab were conducted in
order to determine how effects of the single sleep fragmentation night compares to
postpartum outcomes on these measures. A previous longitudinal study conducted in
the lab continuously monitored sleep and daily PVT among new mothers across the first
12 postpartum weeks; mood surveys were administered biweekly and an MSLT was
conducted among 21 of these women at postpartum week six. The number of lapses
worsened across the early postpartum period, supporting a cumulative effect of sleep
disturbance during this period, and lapses were significantly higher than controls at
each week (Insana et al, 2013). At six weeks postpartum, mothers experienced
moderate sleepiness on the MSLT (sleep onset latency average = 11.8, SD = 4.6)
(Insana, 2010). Mood scores on the POMS were collected after odd-numbered weeks.
Data on the mood scores are unpublished, but available for analyses.
Methods
Participants
Target Sample
Participants were healthy, childless women between the ages of 18-40. Only
women were included in the current study because of the hormonal differences between
men and women and the inadequate power of this small sample-size study to split
analyses based on sex. Furthermore, women were chosen over men because mothers
are still the primary parent responsible for nocturnal infant caregiving (Insana, Garfield,
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& Montgomery-Downs, in press). Participants were excluded based on the following
criteria (see Figure 2):
•

History, current diagnosis, or high risk for major depressive disorder (≥16 score
on the Center for Epidemiologic Studies Depression (CES-D) Scale (Radloff,
1977) (Appendix A)

•

Symptoms of Premenstrual Dysphoric Disorder (PMDD), in accordance with the
DSM-IV (Appendix A)

•

Blindness or any type of ocular light perception dysfunction (including color
blindness)

•

Significant medical illness that put the participant under routine physician care

•

Sleep disorder identified by a history of or symptoms (Appendix A)

•

Drug or alcohol use (≥3 score on the Drug Use Questionnaire [DAST-10]; ≥3
score on the Short Michigan Alcohol Screening Test [SMAST]) (Appendix A)

•

Irregular sleep schedule, travel across more than 1 time zone, or working night
shifts within the month before the study

•

Extreme sleep periods – habitual bedtimes prior to 9pm or later than 2am, and
wake times prior to 6am or later than 11am

•

Excessive napping, defined as napping ≥3 times during the baseline week

•

Excessive daytime sleepiness, or a score of ≤8 on a baseline Multiple Sleep
Latency Test (MSLT)
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Figure 2. Study eligibility decision tree.
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Participants who were deemed ineligible for the study on the basis of high risk for major
depressive disorder or symptoms of a sleep disorder were provided with information
about resources for evaluation and treatment.
Recruitment occurred via word-of-mouth and community advertisements placed
to encourage a large range of socioeconomic status and diverse racial/ethnic
participants. The target sample size was n=10, which was derived from effect sizes
calculated based on previous studies. G Power Version 3.1 was used to derive required
sample sizes (Faul, Erdfelder, Land, & Buchner, 2007). Power = 0.8 and a two-tailed
alpha = 0.05 were the criterion in each of the analyses.
Power Analyses
Target power for melatonin analyses:
Based on effect sizes (d=2.30 and d=2.78) calculated from previous studies that
compared melatonin suppression of acute light exposure during a 30 minute nocturnal
awakening (Bojkowski et al., 1987; Gooley et al., 2011, respectively) and between
constant light or dim light overnight, a sample size of n=4-5 for a within-subjects design
was required to achieve necessary power.
Target power for Polysomnography (PSG) analyses:
Previous studies of changes in sleep architecture after one night of experimental
sleep fragmentation have used sample sizes of 36 subjects (Roehrs et al., 1994) and 11
subjects (Bonnet, 1985). However, based on the effect sizes from Roehrs et al. (1994)
comparing changes in percentage of time spent in SWS (d = 2.11) and time spent in
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stage 1 sleep (d = 1.06) between baseline and sleep fragmentation nights, a sample
size of N = 5-10 for a within subjects design was required to achieve necessary power.
Target power for MSLT analyses:
A sample size of approximately 10 per group (n=20) is typically reported in the
literature when examining differences in levels of sleepiness between groups using the
MSLT (Geisler et al, 2006; Afifi et al 2005). Based on an effect size (d = 1.02) calculated
using a larger sample of 36 healthy young adults’ changes in MSLT scores after a night
of experimental sleep fragmentation, a sample size of N = 10 for a within-subjects
design was required to achieve necessary power.
Target power for recovery analyses:
Sample sizes of roughly 10-15 subjects are commonly reported in the literature
when examining recovery sleep and performance from sleep disturbances (Bonnet,
1985; Axelsson et al, 2008; Sallinen et al, 2008; Wehrens, Hampton, Kerkhofs, &
Skene, 2012). Within these studies, large effect sizes (range: d = 0.87-2.24) have been
reported, suggesting adequate sample sizes to examine recovery from experimental
sleep fragmentation.
The above power analyses and previous study success supported the attained
sample size of N = 11 for a within subjects design with 80% power at an alpha = 0.05.
Compensation
Each participant received $15 per week of at-home actigraphy based sleep/wake
monitoring, plus an additional $20 for each overnight PSG and daytime MSLT, resulting
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in $130 for each participant’s successful completion of the entire study. Participants who
failed to complete the entire study were compensated at half the rate for each
successful portion she did complete.
Measures
Urinary 6-sulphatoxymelatonin (aMT6s)
At the end of the baseline and experimental sleep fragmentation nights,
participants provided an overnight urine sample to assess 6-sulphatoxymelatonin
(aMT6s), the primary metabolite of melatonin, to answer Research Question #1. The
hormone melatonin is the gold standard biomarker for the central circadian clock and
can be measured in plasma, saliva, or urine (Benloucif, et al., 2008). The main
advantage of using urinary aMT6s is sampling can occur overnight without any
additional sleep disturbances. Saliva sampling overnight would require participants to
be awake at night to provide samples. Levels of melatonin in plasma are about three
times greater than that of saliva, allowing for a greater resolution and sensitivity than
saliva or urine methods. If sampling occurs at frequent intervals, plasma melatonin
provides the strongest signal of the three methods, making it a preferred method.
However, plasma sampling is a more expensive and invasive procedure that requires
an indwelling catheter inserted into a participant’s vein to allow continuous collection of
plasma melatonin overnight.
Urinary aMT6 does not allow for the precise measurement of evening melatonin
onset, but allows for assessing overnight concentration of melatonin (Matthews, Guerin,
& Wang, 1991). After participants’ morning void, urine was stirred in the commode hat
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to homogenize and then divided into two approximately 50 mL aliquots. One aliquot was
transported to WVU Hospital’s Laboratories, where the sample was centrifuged and
creatinine was analyzed within 24 hours by the Alkaline Picrate method. aMT6
concentration varies with urine volume, yet in practice, urine volume can be difficult to
accurately measure. However, renal clearance can be estimated when urine volume is
unknown through measurement of creatinine. Creatinine was collected as part of the
current study’s protocol to control for urine concentration in order to overcome
methodological issues in obtaining exact urine volumes (Klante, Brinschwitz, Secci,
Wollnik, & Steinlechner, 1997).
The other aliquot was centrifuged the same day as collection in Dr. Kinsey’s
laboratory in the Life Science Building for 5 minutes at 2000 x g. A 1 mL aliquot was
pipetted into a small test tube to be stored separately and used for the aMT6 analysis.
This was to prevent repeated freeze thaw cycles if multiple testing on the urine samples
was needed. Both samples were immediately stored in a -20°C freezer. Within the
week, these samples were transferred into a -80°C freezer for long-term storage
(samples can be stored at ≤-20°C for up to 1 year). Once all samples were collected,
batch assay was conducted according to ALPCO’s (Salem, New Hampshire) aMT6
enzyme-linked immunosorbent assay (ELISA) kit’s protocol.
Overnight Polysomnography (PSG)
The established 10-20 system was used to set up participants for PSG (Klem,
Luders, Jasper, & Elger, 1999). Minimum montage used included central referential
electroencephalogram C3 and C4 (backup), occipital referential electroencephalogram
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O1 and O2 (backup), right and left electro-oculogram leads, 2 submental
electromyogram leads on the participant’s chin, and electrocardiogram. High resolution
video monitoring simultaneously collected video recording and was used to help score
sleep. In addition to the minimum montage described above, on the first PSG
adjustment/screening night, abdominal and thoracic respiratory belts, an oral/nasal
thermistor, a snore sensor, and a pulse oximeter were used to screen for respiratory
disorders of sleep. Leg EMG sensors were placed on the anterior tibialis muscles to
screen for Periodic Limb Movement Disorder. These extra channels provided the data
necessary to detect a sleep disorder, if present. When the first night of screening
indicated no sleep disorders, the participant continued in the study and the next two
nights (baseline and experimental) used the minimal montage to increase ease of
movement overnight and reduce discomfort of excess wires. The overnight PSG
protocol allowed for precise examination of time spent in sleep stages (these cannot be
measured using actigraphy) that is needed to address Research Question #2.
Multiple Sleep Latency Test (MSLT)
The laboratory-based Multiple Sleep Latency Test (MSLT) was used as an
objective measure of daytime sleepiness, operationally defining the degree of
sleepiness as sleep latency (Afifi et al., 2005). Daytime sleepiness is a complex system
unlikely to be easily measured through just one method. Objective measures of
sleepiness, such as the MSLT and Maintenance of Wakefulness Test (MWT), have
typically been used in preference over subjective measures, which lack sensitivity and
specificity (Coelho, Narayansingh, & Murray, 2011). The MSLT is considered the gold
standard measure of sleepiness and has been used to diagnose narcolepsy and sleep
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disorders with a secondary presentation of excessive daytime sleepiness (Arand et al.,
2005; Mitler et al., 1979; Van den Hoed et al., 1981). The protocol for the proposed
study followed standardized, established guidelines for the MSLT (Littner et al., 2005).
The MSLT required participants’ sleep to be monitored for one to two weeks prior to the
test via actigraphy or sleep/wake diaries. Participants were asked to refrain from
caffeine and alcohol the day of the MSLT. On the day of the MSLT, participants came
into the laboratory and were given four nap opportunities, each spaced at 2 hour
intervals from each other, with the first nap beginning 1.5-3 hours after termination of
nocturnal sleep. Each nap opportunity was 20 minutes in duration and participants were
in a quiet, dark bedroom and instructed to “Please lie quietly, assume a comfortable
position, keep your eyes closed and try to fall asleep.” The minimum montage described
above for the second and third overnight PSG was used. High resolution video
monitoring simultaneously collected video recording and was used to help score sleep
onset as well as ensure participants remained awake during the breaks between MSLT
naps. Sleep latency time was defined as the time it takes from lights out to the first 30second epoch of any sleep stage using the American Academy of Sleep Medicine’s
2008 rules for PSG sleep stage scoring. In any of the nap opportunities, if sleep did not
occur, the sleep latency was recorded as 20 minutes. The outcome measure of the test
was the average sleep onset latency from the 4 nap opportunities and was used to test
the hypothesis for Research Question #3, as well as to screen participants at baseline
for eligibility in the study. Interpretation of the MSLT scores typically follows a ‘rule of
thumb.’ Average sleep onset latency scores ≤5mins indicate pathological level of
daytime sleepiness and scores between 10 and 20 minutes are considered normal
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levels of sleepiness. Scores between 5 and 10 minutes fall into a diagnostic grey area
(Afifi et al., 2005). The use of a baseline MSLT score of ≤8 as exclusion criteria in the
current study is based on the definition of sleepiness for diagnostic purposes, as
identified by the International Classification of Sleep Disorders (AASM, 2005).
Actigraphy
Sleep/wake periods were monitored at home using Mini Mitter’s Actiwatch-64
(AW-64) actigraphs (Bend, Oregon). The actiwatch looks and is worn like a wrist watch
on the participant’s non-dominant wrist. It uses an accelerometer sensor to interpret
movement; these data on movement intensity were downloaded onto the laboratory
computer via a reader. The actiwatch was programmed at the most sensitive 15-epoch
setting, which allowed up to 11 days of continuous monitoring. Because actiwatches
record motion like an accelerometer, periods of nocturnal sleep and daytime naps were
identified using the sleep diary filled out by participants on their personal digital
assistant (described below) to corroborate data from actigraphy outputs. The Actigraph
software was used to calculate total sleep time and ensure participants maintained a
regular sleep schedule during the baseline period, as well as to assess recovery for
Research Question #4. Actigraphy has been well-validated for detecting sleep/wake
patterns among adults (Benson et al., 2004; Edinger, Means, Stechuchak, & Olsen,
2004; Morgenthaler et al., 2007; Sadeh, 2011). Its advantage over the traditional, gold
standard PSG is that it can conveniently record continuously for long periods of time,
and it allows for measurement of sleep patterns in the field. It has been correlated with
PSG for differentiating sleep from wake, with 91% agreement rates (de Souza et al.,
2003).
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A Palm Zire 72 handheld personal digital assistant (PDA) was used to collect
field-based sleep and actiwatch diaries. These diaries behaviorally corroborated
actigraphy data and are essential to help control artifact that could misidentify periods of
immobility as sleep (Acebo & LeBourgeois, 2006). Further, an electronic diary was
chosen over a paper and pencil diary because of improved adherence to filling out logs
when using an electronic diary compared to paper-and-pencil logs (Stone, Shiffman,
Schwartz, Broderick, & Hufford, 2002) as well as participants’ reported increased
preference for the electronic over paper version in recording of behaviors (Lam et al.,
2010) and infant sleep (Müller, Hemmi, Wilhelm, Barr, & Schneider, 2011).
Psychomotor Vigilance Test (PVT)
The psychomotor vigilance test (PVT) was self-administered using the PDA each
morning within two hours after awakening and prior to the consumption of any caffeine
to prevent possible caffeine-related or circadian alerting effects (Lim & Dinges, 2008).
Each test lasted 5 minutes, during which stimuli were presented at random interstimulus intervals. The use of this 5-minute test is supported by a validation of PVTs
less than 10 minutes in duration (Loh, Lamond, Corrian, Roach, & Dawson, 2004).
Reaction times were recorded for response to each individual stimulus, and the number
of lapses (reaction times ≥500ms) was calculated from the reaction times. The PVT has
become the predominant test of vigilant attention used in sleep research because of its
high sensitivity to sleep deprivation, predictive ability of performance in simulated driving
tasks, and relatively minor learning effects (Basner & Dinges, 2011; Jackson, Croft,
Kennedy, Owens, & Howard, 2013; Lim & Dinges, 2008). The frequency of lapses was
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used to assess recovery of performance after experimental sleep fragmentation for
Research Question #4.
Profile of Mood States (POMS)
The Profile of Mood States (POMS) (Appendix A) was administered in the
laboratory prior to and after the experimental sleep fragmentation, and it was given to
each subject to self-administer at home each day for the recovery week (automatic text
messages were sent from the research team to remind the women to fill this out). The
POMS consists of 65 adjectives rated by participants using a 5-point Likert scale. Six
subscales have been derived from the POMS: tension-anxiety, depression-dejection,
anger-hostility, fatigue-inertia, confusion-bewilderment, and vigor-activity. Subscale
ranges vary: tension-anxiety (0–36); depression (0–60); anger-hostility (0–48); fatigue
(0–28); confusion bewilderment (0–28); and the reverse-scored vigor-activity subscale
has a range from -32 to 0. A POMS Total Mood Disturbance (TMD) score is derived
from the addition of the six subscale scores, has a range from -32 to 200, and is an
indicator of a global dimension of mood disturbance. POMS TMD scores and all but the
vigor-activity subscale are negative dimensions, so high scores represent worse mood.
Survey responses reflected the participant’s mood during the past day. Internal
consistencies of the POMS when administered to adults 17-60 years old ranged from
0.84 (confusion-bewilderment scale) to 0.95 (depression-dejection scale) (McNair, Lorr,
& Droppleman, 1992). Scores on the POMS were used to assess recovery of mood
after experimental sleep fragmentation for Research Question #4.
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Procedure
Once participants were identified, they came into the laboratory where a
researcher gave a laboratory tour, described the research protocol in full, provided
instructions for using the equipment (actigraph and PDA), described the surveys,
collected demographic information, and answered any residual questions from
participants. Informed consent and a Health Insurance Portability and Accountability Act
(HIPAA) authorization were administered to participants. The procedure for the study is
illustrated in Figure 1, and is split into 3 phases.
Phase I
Participants began the study with a 7-day field based protocol, which served both
to normalize sleep and provide a baseline measurement after which the experimental
night was compared. Participants were also asked to keep a consistent, approximately
8-hour sleep period (more if needed) with a bedtime based on habitual sleep periods.
Participants wore an actigraph on their non-dominant wrist and filled out on their PDA:
when they put on and took off the actigraph, a sleep diary, and completed a PVT each
morning within 2 hours after awakening. The nightly sleep time and average daily
number of lapses on the PVT were averaged across the week to create stable baseline
measures.
Phase II
At the end of the 7-days, participants came into the laboratory for the second
phase, a laboratory-based protocol. They came into the laboratory about 1-1.5 hours
after awakening on the 7th day so that research personnel could apply the PSG sensors
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before the first MSLT nap opportunity (scheduled 1.5-3 hours after awakening that
morning). Prior to or immediately after the first nap opportunity, a researcher
downloaded the data from the week of actigraphy to ensure participants followed
protocol and determine average bedtime, rise time, and time spent in bed (these values
were used for the in-laboratory nights). Participants underwent the MSLT, conducted
according to standardized protocol (Littner et al., 2005). Between nap opportunities
participants remained in the laboratory and engaged in leisure activities such as
reading, watching a movie, using the internet, or anything else that involved low levels
of activity. They brought a lunch and snacks, as this was not be provided by the
researcher team. Participants were continuously monitored with video recording to
ensure they did not fall asleep between the nap opportunities. Additionally, they filled
out the POMS survey between naps.
At the end of the MSLT day, participants who had average sleep onset latencies
equal to or less than 8 minutes were disqualified from the study. Otherwise, they were
allowed to go home for a few hours, and then asked to come back about 1.5 hours
before their habitual bedtime (determined via actigraphy data from baseline week) to get
set up for the first overnight PSG. Participants slept according to their habitual sleep
periods determined by baseline actigraphy data. This night served as an adjustment
night in order to account for the first-night effect, which is a phenomenon by which
participants experience increased awakenings, decreased time spent in REM sleep,
longer latencies to SWS and REM, and a greater number of stage changes during the
first night spent in a sleep laboratory (Agnew, Wilse, Webb, & Williams, 1966). It also
served to ensure none of the participants had a sleep disorder. Data from this night
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were not used in subsequent analyses. After the first night, participants had sensors
removed, left the laboratory, and were instructed to come back that night. During their
day away from the laboratory, participants refrained from napping, and wore their
actiwatch.
The second night of the protocol was conducted in the same manner as the first
night but was used as a baseline night for subsequent analyses. Urine was also
collected overnight for the measurement of aMT6. Participants voided urine within 10
minutes of bedtime. Consistent with other studies collecting overnight aMT6, this prebedtime void was not collected for analysis (Davanipour, Poulsen, Weimann, & Sobel,
2009; Roach et al., 2005). From that point on, all urine passed during the night was
collected in a commode hat and remained there at room temperature. At the end of the
sleep period, participants voided urine into the commode hat. After the pre-bedtime
urine void, participants were kept in dim light (12 lux in the direction of gaze one meter
away, or more accurately, 3.5 lux from the participant’s perspective lying in bed, verified
by a light meter) while bio-calibrations were conducted until lights out. The bedroom
was completely dark during sleep periods (0 lux). A red light was used in the bathroom if
participants awakened in the middle of the night to void. Dim and red light were used in
order to minimize the impact of light on 6-sulphatoxymelatonin (aMT6s) secretion.
Participants returned home after the second night.
On the third night, participants again came into the laboratory about 1.5 hours
before bedtime to get hooked-up for PSG. This night served as the experimental night.
Based on data from our lab indicating women report an average of 2.9 awakenings
each night during the second postpartum week (Winser, 2012), and the
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recommendations from the AAP that breastfed newborns should be fed at intervals
between 1.5-3 hours, mothers were awakened 3 times throughout the night. Previous
literature indicates feeding time is approximately 13.8-16 minutes (De Carvalho et al.,
1982; Thoman et al., 1971), but that mothers spend an additional 12 minutes engaged
with the infant in non-feeding activities (Thoman et al., 1971). Based on the combination
of these data and literature, it was decided the protocol for the current study would
consist of 3 awakenings of about 30-35 minutes each, spaced equally apart throughout
the night. Each participant’s bedtime and habitual time spent in bed was preserved;
scheduled awakenings added into the sleep period resulted in a rise time that was 1 hr
30 mins – 1 hr 45 mins later than typical for each participant.
No published data exist on the activities new mothers engage in at night. The
current protocol for the 35 minute awakenings was therefore not based on research.
However, it was based on anecdotal information from mothers and was standardized for
each participant. Posture and lighting levels (1 lux in the direction of gaze, verified by a
light meter) during each awakening were kept consistent between participants because
both changes in posture and lighting levels can impact melatonin levels and sleepiness
(Cajochen et al., 2005; Deacon & Arendt, 1994; Gooley et al., 2011). Each participant
was told that they would be awakened three times throughout the night by an audio clip
of a baby crying via an intercom next to the participant’s bed. The crying baby was
sufficient to wake each participant for each awakening, confirmed by EEG data. They
were then given the following standard instructions via the intercom during each of the
three awakenings:
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1. Pick up the baby doll, change the doll’s diaper with a diaper that was in the
participant’s room (5 minutes - participant was standing during the procedure).
2. Sit in the rocking chair and pretend to feed the baby doll with the bottle provided
(15 minutes – participant was seated)
3. Burp the baby (5 minutes – participant was seated)
4. The participant was then asked to stand and put the baby back down on the
spare bed, and was allowed to go to the bathroom (if needed) (5 minutes –
participant was standing)
5. The researcher entered to fix any PSG sensors that had fallen off, after which the
participant will be told to go back to bed.
The researcher entered the room each time the participant was moved from one
posture to another to ensure participants did not trip over or drop the equipment in the
dimly lit room. In some circumstances, the researcher also entered to provide the
participant with an extra blanket. During all interactions with the participant at night,
conversation was kept to a minimum. Once participants were awakened in the morning,
first morning void was collected (and combined with all samples from any time they
used the bathroom overnight). They remained in the laboratory that day for the second
MSLT (which began 1.5-3 hours after awakening). The MSLT was conducted as
described above during the baseline session.
Phase III
After the laboratory Phase II, participants went home and their sleep was
monitored with actigraphy and a sleep diary on the PDA for 7 nights, and they self-
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administered the PVT each morning within 2 hours after awakening (same protocol as
the first 7 nights of the study, except sleep was ad libitum). The POMS was filled out
every other day to capture changes in mood during recovery. At the end of the study, a
researcher picked up the equipment from the participant either in the laboratory or at a
location convenient for her. After full participation in the study, each participant received
$130 in compensation.
Results
Participants
Women were recruited via university-wide and the Department of Psychology
listservs, an ad on Craigslist, and word of mouth between March and November 2013.
Figure 3 illustrates how many women expressed initial interest and then declined to
begin or continue participation, or were excluded at various points throughout the study.
Based on an a priori power analyses, the target sample size was n=10. An extra
participant was included in case one participant’s data were incomplete or an outlier on
any measure was found, and had to be excluded post-hoc. As no post-hoc exclusions
were necessary, 11 women contributed data to the study. Women who completed the
study were all nulliparous with no reported history or current symptoms of depression,
as defined by a score of <16 on the CES-D (Radloff, 1977); they did not report
symptoms of premenstrual dysphoric disorder (PMDD) and all had regular menstrual
cycles (defined as being confident in their ability to predict when their period will start, to
the week); they did not work night shifts or travel through >1 time zone during the month
prior to participating in the study; these women did not report blindness or visual
impairments that would interfere with the production of melatonin; they did not have a
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major medical illness for which they received routine physician care; were not smokers;
they consumed no more caffeine per day than the amount in two 6-oz cups of coffee,
consumed on average <3 alcoholic drinks per week, and were told not to have any
alcoholic beverages the day of any overnight polysomnography (PSG).
Based on the PSG screening night, no participant had any respiratory events.
Three of the completed participants had periodic limb movements in sleep (PLMS), with
the highest number of PLMS/hour at 8.3 for one participant (periodic limb movements
with associated arousals [PLMA]/hour=1.0). The other two had PLMS/hours indices of
2.6 (PLMA=0.8) and 1.6 (PLMA=0). The International Classification of Sleep Disorders
(AASM, 2005) requires >15 PLMS/hour along with a clinical sleep disturbance or
complaint of daytime fatigue before it is considered a sleep disorder. As PLMS are
common findings on PSG recordings, and none of these participants had clinically
significant levels of PLMS that were consistent with a disorder, had complaints of
daytime fatigue, or showed signs of excessive daytime sleepiness (based on recorded
MSLT scores), all participants’ data were included in the final analyses.
Demographic characteristics of the total sample are in Table 1. Between-groups
one-way Analysis of Variances (ANOVA) and chi-square tests were used to analyze
whether the participants who began but did not complete the study differed from those
who completed the study. No differences were found between groups on any
demographic variable or baseline actigraphically-recorded total sleep time.
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Figure 3. Flowchart of participants throughout the study.
Women who expressed interest in the study (n=189)

Excluded* (n=162)

Women who completed the phone screening (n=27)

Excluded (n=8)
#
Based on ineligibility (n=4)
Scheduling conflict arose prior to start of study (n=4)

Women who began the study (n=19)

Excluded (n=8)
Dropped out due to scheduling conflicts (n=2)
Based on ineligibility^ (n=6)

Women who successfully completed the study (n=11)

*Did not differentiate between those who were unable to participate due to scheduling
difficulties and those who were no longer interested.
#
Reasons for ineligibility to begin study: on antidepressant medication (n=1), symptoms
of a sleep disorder (n=2), major medical condition (n=1).
^Reasons for ineligibility to continue study: sleep/wake times differed across baseline
week by >3 hours (n=1), score <8 on MSLT (n=4), sleep disorder symptoms on
screening night (n=1).
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Table 1.
Participant demographics
Participant

Age

Income

Years of
Race/Ethnicity
Education

BMI

Marital Status

Work Status

Married/Living
Unemployed
Together
Married/Living
22.7
Full-time Student
Together

M-E
Score

Baseline
TST
(hh:mm)

No

35

8:17

Yes

44

7:05

119

29.8 $50,000

18

Asian

122

23.2 $20,000

17

Biracial

326

26.1 $12,000

19

Asian

20.4

Single

Full-time Student

No

43

8:24

355

23.0 $12,000

17

White

26.0

Single

Full-time Student

Yes

67

7:05

391

26.1 $30,000

18

White

23.2

Single

Full-time Student

No

48

8:05

412

24.4 $15,000

18

White

23.3

Married/Living
Full-time Student
Together

No

78

7:32

474

26.2 $13,500

20

White

19.1

Single

Full-time Student

Yes

71

7:52

533

23.9 $25,000

17

White

20.5

Single

Full-time Student

No

61

6:53

696

23.2 $25,000

16

White

23.1

Married/Living
Full-time Student
Together

Yes

52

8:22

827

29.0 $32,000

18

White

35.6

Single

Full-time

Yes

54

7:16

886

23.8 $20,000

17

White

25.4

Single

Full-time Student

Yes

42

7:41

Mean/
Percentage

25.4 $23,100

17.7

72.7% White

23.3

63.6% Single

81.8% Full-time
Student

54.5%
Yes

54.1

7:41

2.3

1.10

13.6

0:33

Standard
Deviation

11,300

16.9

Hormonal
Birth
Control

4.8

M-E=Morningness-Eveningness Questionnaire; TST=Total Sleep Time; BMI calculated from participants’ weights and heights in the
laboratory during consent visit; Participant numbers generated with online random number generator (http://www.random.org)
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Data Management
Data were checked for missing variables prior to conducting analyses. One
Psychomotor Vigilance Test (PVT) data point was missing on the first day of the study
for a single participant due to participant non-adherence. One night of actigraphy data
was missing on the third day of the recovery week due to participant non-compliance
(she forgot to put the actigraph back on before she went to sleep). Pairwise deletion
was used in these cases. One participant had 40 minutes of unscoreable data during
the baseline overnight PSG due to technician error. Percentage of time spent in each
sleep stage for this participant was based on the total sleep that was scored. On one of
the post-fragmentation MSLT nap opportunities, a participant had an unscoreable
recording because of PSG equipment malfunction after the nap opportunity had started.
The participant’s MSLT score was based on the three usable naps.
SPSS version 21.0 was used for data analysis. For all of the following analyses,
a p<.05 was considered statistically significant, except in noted cases where a
Bonferroni correction was used. Partial eta squared (η2p) (small=.01, medium=.06,
large=.14), Cohen’s d (small=.2, medium=.5, large=.8), and Cramer’s V (small=.1,
medium=.3, large=.5) were used to calculate effect sizes.
Normality and Outliers
Continuous variables were checked for skewness and kurtosis. PVT lapse
frequency on the 7th day of the recovery period was slightly leptokurtic (Kurtosis/SE
Kurtosis=3.3). Square root transformation was sufficient to achieve normality, and
analyses were run on the transformed and untransformed variable. However, statistical
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results did not differ; therefore, results are reported on untransformed values. Percent
time spent in REM sleep on the sleep fragmentation night was slightly negatively
skewed (Skewness/SE Skewness=-3.2) and leptokurtic (Kurtosis/SE Kurtosis=3.9).
Square root and logarithmic transformations were insufficient to achieve normality, so
non-parametric statistics were used when analyzing this variable. All other overnight
PSG, actigraphic, MSLT, and POMS TMD data were normally distributed with no
outliers.
Results for Research Question #1
RQ#1: How does a single night of experimentally-simulated postpartum sleep
disturbance affect nocturnal melatonin release among healthy nulliparous
women?
The intra-assay coefficient of variation of the ELISA was 4.4%. The results did
not support the hypothesis, that one night of postpartum-like sleep disturbance will
cause a suppression of 6-sulphatoxymelatonin compared to the baseline night. A paired
samples t-test was run to test for differences in 6-sulphatoxymelatonin (aMT6)
concentration between baseline and sleep fragmentation nights. There was not a
significant difference between aMT6 concentrations following the baseline (M=23.3,
SD=13.5) and sleep fragmentation nights (M=25.0, SD=12.2; t[10]=.69, p=.51, d=.09)
(see Figure 4).
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Figure 4. aMT6 concentrations during baseline and sleep fragmentation
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Research Question #1: Supplemental Analyses
Because Figure 4 indicates individual differences in changes in aMT6
concentration, participants change score (baseline aMT6 concentration - sleep
fragmentation aMT6 concentration) was compared to selected demographics that either
had sufficient variation within the sample to test for differences (income and baseline
TST) or were of particular interest to circadian outcomes (use of oral contraception and
M-E scores) to determine whether certain individual differences were driving differences
in aMT6 changes. Correlations for continuous measures (income, M-E scores, baseline
TST) and a t-test (for the categorical measure use of oral contraception) revealed no
relation between any of these demographic variables and the change in aMT6
concentration.
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Results for Research Question #2
RQ#2: How does a single night of experimentally-simulated postpartum sleep
disturbance affect sleep architecture among healthy nulliparous women?
Following the American Academy of Sleep Medicine’s (AASM) standard scoring
criteria, all overnight PSG studies were scored by two independent analysts (HMD and
ALM), one who was blind to the participants’ identity (HMD). Blinding to the condition
(whether it was the initial adjustment night, baseline, or sleep fragmentation night) was
not possible because the recording montage differed between the adjustment and
subsequent nights, and because the forced awakenings on the experimental night could
be easily differentiated from the baseline night. However, the order of scoring of both
participant and condition were randomized for HMD so that she did not score either
participants or their PSG records chronologically. Minor discrepancies between HMD
and ALM were settled by consensus so that the final agreement on the overnight stage,
arousal, and event scoring was 100%.
To determine whether the protocol was successful at simulating postpartum
sleep disturbance (maintaining total sleep time and decreasing sleep efficiency during
the experimental night compared to the baseline night), two paired samples t-tests were
conducted to test the difference in total sleep time and sleep efficiency between the
baseline and sleep fragmentation nights. There was not a significant difference in total
sleep time between baseline (M=461min, SD=28min) and experimental nights
(M=448min, SD=34min; t[10]=1.49, p=.17, d=.42). There was a significant decrease in
sleep efficiency from baseline (M=90.9%, SD=6.1%) to experimental nights (M=74.4%,
SD=3.9%; t[10]=9.31, p<.001, d=3.20). The protocol was also successful in awakening
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each participant three times equally spaced throughout the night of approximately the
same duration for each awakening (see Table 2). In sum, these data support that the
sleep fragmentation protocol was successful in simulating postpartum sleep
disturbance.
Table 2.
Descriptive information on sleep fragmentation night
Mean (min)

SD (min)

Range (min)

Awakening 1

32.9

3.2

29.8 - 38.7

Awakening 2

31.8

1.8

29.6 - 34.7

Awakening 3

32.4

2.5

29.9 - 37.1

Mean (hh:mm)

SD (hh:mm)

Range (hh:mm)

2:06

0:09

1:48-2:21

2:06

0:07

1:59-2:20

2:06

0:07

2:00-2:19

2:06

0:07

1:56-2:18

Duration of
Awakenings

Duration Between:
Lights Out &
Awakening 1
Awakenings 1 & 2
Awakenings 2 & 3
Awakening 3 &
Lights On

Hypothesis 2a, that the percentage of time spent in stage N1 sleep will be
increased in the experimental night compared to the baseline night, was not supported.
A paired samples t-test using a Bonferroni correction (p=.012) was run to test for
differences in time spent in stage N1 sleep between baseline and sleep fragmentation
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nights. There was not a significant increase in the proportion of time spent in stage N1
during the sleep fragmentation night (M=6.7%, SD=2.5%) compared to baseline
(M=4.3%, SD=2.4%; t[10]=2.77, p=.02, d=.97) (see Figure 5).
Hypothesis 2b, that the percentage of time spent in stage N2 sleep will be
increased in the experimental night compared to the baseline night, was not supported.
A paired samples t-test using a Bonferroni correction (p=.012) was run to test for
differences in time spent in stage N2 sleep between baseline and sleep fragmentation
nights. There was not a significant increase in stage N2 sleep on the sleep
fragmentation (M=39.7%, SD=5.4%) night compared to baseline (M=43.5%, SD=8.3%;
t[10]=1.83, p=.10, d=.55) (see Figure 5).
Hypothesis 2c, that the percentage of time spent in stage N3 sleep will be
reduced in the experimental night compared to the baseline night, was not supported. A
paired samples t-test using a Bonferroni correction (p=.012) was run to test for
differences in time spent in stage N3 sleep between baseline and sleep fragmentation
nights. There was not a significant decrease in stage N3 sleep on the sleep
fragmentation night (M=30.2%, SD=4.8%) compared to baseline (M=28.8%, SD=6.3%;
t[10]=.64, p=.54, d=.24) (see Figure 5).
Hypothesis 2d, that the percentage of time spent in REM sleep will be reduced in
the experimental night compared to the baseline night, was not supported. With a
Bonferroni correction (p=.012), there was not a significant decrease in REM sleep on
the sleep fragmentation (Mdn=25.9%) night compared to baseline (Mdn =22.9%) with
the Wilcoxon’s signed-rank test, Z=.44, p=.66, r=.13 (see Figure 5).

EFFECTS OF A POSTPARTUM SLEEP SCHEDULE 51

Figure 5. Time spent in each sleep stage between baseline and sleep
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Research Question #2 Supplemental Analyses
Because interesting patterns emerged through visual analysis of the data,
comparisons were made to determine whether sleep onset latency following each of the
three forced awakenings changed across the sleep fragmentation night. A repeatedmeasures ANOVA was used to test for a polynomial shape across time. There was a
significantly linear trend of decreasing sleep latencies across the night (F[2]=11.2,
p=.007, η2p =.53) (see Figure 6).
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Figure 6. Sleep onset latency after each successive forced awakening on the
sleep fragmentation night (Error bars represent SE).
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Results for Research Question #3
RQ#3: How does a single night of experimentally-simulated postpartum sleep
disturbance impact daytime sleepiness among healthy nulliparous women?
The Multiple Sleep Latency Test (MSLT) was scored in real-time per standard
scoring criteria (Littner et al., 2005) and was then also examined 3 months after data
collection was completed independently by both ALM and HMD. Both were blind to
whether the test was pre or post sleep fragmentation and their order was randomized to
prevent an order effect of systematic changes across participants. HMD had
administered 2% and ALM administered 56% of the MSLT nap opportunities. The
retrospective scores were then compared to each other and to the original real-time
scores. There was a 47.7% agreement rate on each nap opportunity between HMD
retrospective scoring and the original scoring. Systematic discrepancies were observed
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between the original and retrospective scores: when the original MSLT was
administered by a research assistant, there was greater discrepancy between the
original and retrospective scores. ALM administered 86% of the baseline MSLT nap
opportunities; research assistants administered 89% of the post-fragmentation MSLT
naps opportunities. To avoid errors in the planned comparisons due to systematic
differences in scoring, MSLT scores were retrospectively changed according to rules
described in Appendix A.
In accordance with standard criteria, the baseline week of actigraphy
simultaneously served as monitoring to ensure sufficient sleep prior to the MSLT,
specifically that the night prior to the MSLT was representative of the participants’
normal sleep (Littner et al., 2005). A t-test performed comparing the average total sleep
time of the first six days of the baseline week (M=462, SD=33) to the seventh day (the
night before the MSLT) (M=454, SD=53) confirmed there was no significant change in
total sleep time (t[10]=.65, p=.53, d=.19).
The hypothesis that sleep fragmentation would cause greater daytime sleepiness
on an MSLT compared to baseline was not supported. A paired samples t-test was run
to test for differences between baseline and post-sleep fragmentation MSLT scores.
There was a significant decrease in objective sleepiness (an increase in the MSLT
score) between the day following baseline (M=13.1, SD=3.54) and the day following
sleep fragmentation nights (M=16.3, SD=3.51; t[10]=2.83, p=.02, d=.92) (see Figure 7).
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Figure 7. MSLT average sleep onset latencies between baseline and sleep
fragmentation nights for each individual participant (Error bars represent SD).
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Research Question #3: Supplemental Analyses
In order to determine whether sleepiness at certain times of the day was driving
the overall improvement in sleepiness, supplemental analyses were made comparing
the MSLT scores of the four individual naps from baseline to post-sleep fragmentation.
A 2 (condition: baseline vs. post-fragmentation) x 4 (each individual nap) repeatedmeasures ANOVA was conducted. A significant main effect of condition was qualified
by a significant condition x nap interaction, F(3)=5.65, p=.004, η2p =.39. Post-hoc
dependent t-tests using a Bonferroni correction (p=.012) determined that there was a
significantly shorter sleep onset latency during the baseline MSLT for the fourth nap
during baseline compared to post-fragmentation, t(10)=3.43, p=.006, d=1.56 (see
Figure 8).
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Figure 8. MSLT sleep onset latencies for individual nap opportunities between
baseline and the day after experimental sleep fragmentation (Error bars
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Because Figure 7 indicates some participants had increases and others had
decreases in MSLT scores, participants change score (baseline MSLT – post-sleep
fragmentation MSLT) was compared to selected demographics (income, birth control pill
use, M-E questionnaire, and baseline TST) to determine whether certain individual
differences were driving differences in MSLT changes. Correlations for continuous
measures (income, M-E scores, baseline TST) and a t-test (for the categorical measure
use of oral contraception) revealed no relation between any of these demographic
variables and the change in MSLT scores.
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Results for Research Question #4
RQ#4: How does a single night of experimentally-simulated postpartum sleep
disturbance impact the next week’s sleep, performance, and mood among
healthy nulliparous women?
Actigraphy Total Sleep Time
Six participants took daytime naps during the study; for these participants, 24hour sleep time was used. Specifically, one participant napped on two days during the
baseline week, two participants napped on two days during the recovery week, and
three participants napped on one day during the recovery week.
In order to test the hypotheses that experimental sleep disruption will cause
increased actigraphy-measured total sleep time on the proceeding at-home recovery
night, compared to baseline at-home total sleep time, and total sleep time will decrease
to baseline levels after the first recovery night, first a repeated-measures ANOVA with
total sleep time as the dependent variable and time since beginning of the study until
the first in-lab day (baseline) was conducted to determine whether total sleep time
changed across the baseline week. There was no significant change in total sleep time
across the baseline week, F[6]=.55, p=.77, η2p =.05 (see Figure 9). These data were
averaged and a paired samples t-test was used to test for differences in the average
total sleep time between baseline and the total sleep time the night after the sleep
fragmentation protocol. The results did not support the hypothesis; there was not a
statistically significant change in total sleep time between the baseline average (M=461,
SD=33) and the night after sleep fragmentation (M=463, SD=83; t[10]=.12, p=.91,
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d=.03). Given the null findings, the second part of the hypothesis that total sleep time
will decrease to baseline levels after the first recovery night, was not tested.
Figure 9. Total sleep time across baseline and post-fragmentation weeks (Error bars
represent SE).
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Performance
In order to test the hypotheses that experimental sleep disruption will cause
worse performance on a psychomotor vigilance test (PVT) on the morning after
experimental sleep fragmentation compared to baseline condition, and will gradually
improve to baseline levels across the recovery week, first two repeated-measures
ANOVAs with frequency of PVT lapses as the dependent variable and either time from
beginning of the study until the first in-lab day (baseline) or time since sleep disruption
as the independent variable were conducted to determine whether frequency of lapses
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changed across baseline and recovery weeks. There was no significant change in
frequency of PVT lapses across the baseline (F[6]=2.72, p=.08, η2p =.23) or recovery
weeks (F[7]=1.31, p=.26, η2p =.12) (see Figure 10).
Given the lack of change in frequency of PVT lapses within each of the baseline
and recovery weeks, the data were averaged and a paired samples t-test was used to
test for differences in the average frequency of PVT lapses between baseline and
recovery weeks. By using the averages of values across baseline and recovery weeks,
the comparisons are more robust to daily performance variations within a week. The
results supported a reduction in performance after sleep fragmentation; there was a
statistically significant increase in frequency of PVT lapses (M=2.72, SD=1.76)
compared to the baseline average (M=1.62, SD=1.83; t[10]=2.98, p=.01, d=.61).
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Figure 10. Frequency of PVT lapses across baseline and post-fragmentation weeks
(Error bars represent SE).
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Mood
In order to test the hypotheses that experimental sleep disruption will cause
higher POMS total mood disturbance scores the day after experimental sleep
fragmentation compared to baseline condition, and will gradually improve to baseline
levels across the recovery week, first a repeated-measures ANOVA with POMS TMD as
the dependent variable and time since sleep disruption as the independent variable was
conducted to determine whether POMS TMD scores changed across the postfragmentation week. As only one baseline measure was taken for this survey, tests for a
change in baseline score were not performed. After a Greenhouse-Geisser correction
because the assumption of sphericity was not met, there was not a significant change in
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POMS TMD scores across the post-fragmentation week (F[3]=.37, p=.65, η2p =.04) (see
Figure 11).
Given the lack of significant change in POMS TMD scores across the postfragmentation weeks, those data were averaged and a paired samples t-test was used
to test for differences in between baseline POMS TMD score and the average POMS
TMD score across the post-fragmentation week. There was a statistically significant
increase from baseline POMS TMD scores (M=-1.00, SD=7.10) compared to the postfragmentation week average (M=8.55, SD=12.9; t[10]=2.40, p=.037, d=.92) (see Figure
11).
Figure 11. POMS TMD between baseline and after experimental sleep
fragmentation (Error bars represent SE).
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Research Question #4: Supplemental Analyses
While analyzing the actigraphy sleep recovery data, there was a trend observed
in napping behavior, with more frequent naps observed after sleep fragmentation.
Therefore, the prevalence of napping before and after sleep fragmentation was
analyzed statistically. A McNemar’s test was conducted to determine whether there was
a change in number of participants who napped before and after experimental sleep
fragmentation. During the baseline week, 9.1% of participants napped compared to
45.5% of participants who napped during the recovery week, however, this was not a
statistically significant difference, p=.22, Cramer’s V=.29. Of the naps taken during the
recovery week, 42.9% were taken the day after the recovery night from the MSLT.
After finding significant differences on the POMS total mood disturbance scale
between baseline and the average of POMS scores post-fragmentation, paired samples
t-tests were conducted on each of the seven POMS subscales to understand
specifically which components of mood were affected by the sleep fragmentation. There
was a significant increase in the fatigue subscale (t[10]=2.38, p=.04, d=.73) and
decrease in the vigor subscale (t[10]=4.26, p=.002, d=1.59) after sleep fragmentation
compared to baseline. There was no significant change on the tension, depression,
anxiety, or confusion subscales (see Figure 12).

EFFECTS OF A POSTPARTUM SLEEP SCHEDULE 62

Figure 12. POMS subscale scores at baseline and the average of subscales
after sleep fragmentation (Error bars represent SE).
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Planned Supplemental Analyses
Comparison to Postpartum Data
There were changes to PVT performance and mood in the current study, so
these data were compared to existing postpartum PVT performance and mood at the
earliest recording period.
PVT Performance
To determine whether there were any performance differences between early
postpartum women and nulliparous women in the current study, an existing database
with frequency of PVT lapses averaged across postpartum week 2 among primiparous
women were compared to the average lapse frequency post-experimentally induced

EFFECTS OF A POSTPARTUM SLEEP SCHEDULE 63

sleep fragmentation in the current study’s sample. The lapse frequency for primiparous
women was positively skewed, so was square root transformed. Levene’s test was
significant, so equal variances were not assumed. An independent t-test indicated the
lapse frequency was significantly greater for postpartum women (M=5.80, SD=4.69)
than nulliparous women in the current study (M=2.72, SD=1.76; t[25.2]= 3.32, p=.003,
d=.87).
Mood
To determine whether there were any mood differences between early
postpartum women and nulliparous women in the current study, existing data of POMS
TMD scores at postpartum week 3 (the earliest time POMS was administered) among
primiparous women were compared to the average POMS TMD scores postexperimentally induced sleep fragmentation in the current study’s sample. The POMS
TMD scores for primiparous women were positively skewed, so these data were square
root transformed. POMS TMD scores were not significantly different between
postpartum women (M=21.4, SD=24.4) and nulliparous women in the current study
across the recovery week (M=8.55, SD=12.9; t[77]= 1.71, p=.09, d=.66).
Discussion
The primary goal of this study was to understand the discrete impacts of
postpartum sleep disturbance on sleep architecture, mood, circadian rhythm amplitude,
daytime sleepiness, and recovery. The average age of the current sample (25.4 years)
was consistent with the average age of first time mothers in the U.S. (25.0 years)
(Laughlin, 2011). However, there were fewer women who were married or cohabitating
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(36.4%) compared to first time mothers in the U.S. (76.3%) (Martinez, Daniels, &
Chandra, 2012). Furthermore, this sample was highly educated, with 100% of
participants earning at least a Bachelor’s degree, compared to 24% of all mothers in the
U.S. (Laughlin, 2011).
A functional model of postpartum sleep fragmentation was established; women
had significantly lower sleep efficiency on the sleep fragmentation night compared to
baseline. The current sample’s PSG-recorded average sleep efficiency (74.4%) was
slightly lower than the actigraphically-recorded sleep efficiency of women in the second
week postpartum (79.7%) (Montgomery-Downs et al., 2010). In an attempt to isolate the
impacts of sleep fragmentation from total sleep time, the time in bed of each participant
from baseline to sleep fragmentation night was preserved. This resulted in a total sleep
time that was only slightly higher than that previously reported among postpartum
women (M=7.46hr±0.56, M=7.2hr±0.95, respectively, Cohen’s d=0.33).
Results indicated no changes in 6-sulphatoxymelatonin (aMT6), time spent in
nocturnal sleep stages, and total sleep time after sleep fragmentation compared to
baseline. There was a significant decrease in daytime sleepiness after fragmentation
compared to baseline, specifically on the fourth and final MSLT nap opportunity.
Performance and mood decrements were seen the week after sleep fragmentation
compared to baseline. Interpretations of these findings are described in respective
sections below.
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Melatonin
The averages of aMT6 concentration among the current sample are consistent
with overnight aMT6 concentrations reported in previous studies. The current sample
had pre- and post- concentrations of 23.3 ng/ml (SD=13.5) and 25 ng/mg (SD=12.2),
respectively, which compares well to creatinine adjusted 6-SMT concentrations found in
premenopausal women (M=28.5 ng/mg, SD=19) (Schernhammer et al., 2004).
The concentration of aMT6 among the current sample did not change between
baseline and sleep fragmentation nights, a finding that did not support the hypothesized
decrease in aMT6 concentration on the sleep fragmentation night compared to baseline.
However, the hypothesis was based on differences in melatonin levels among
postpartum women (Thomas & Burr, 2006) and other populations who experienced
fragmented sleep (Hernandez et al., 2007; Sack et al., 2007) in naturalistic settings, not
in a highly controlled laboratory. Kavčič and colleagues (2011) did measure the
response of melatonin in the laboratory, but they used an experimental sleep
deprivation protocol, not sleep fragmentation, and their subjects were exposed to light at
night, whereas the current protocol was careful to only use a very dimly lit environment
in order to parse out the effects of the fragmentation from the light exposure.
Conversely, results were consistent with recent literature that fragmented the
sleep of healthy men for one night, with preserved total sleep time, and found no
changes in plasma melatonin concentration (Gonnissen, Hursel, Rutters, Martens, &
Westerterp-Plantenga, 2013). This study also utilized a sleep fragmentation protocol
that had longer periods of consolidated sleep (90 mins of sleep before participants were
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awakened); however, the awakenings were very brief (about 2 minutes – enough time
for the participant to confirm awakening by shutting off an alarm). There were no
changes in posture or light exposure during these awakenings.
Based on the existing literature, there are two distinct but possible conclusions
that could be drawn to interpret the findings. The first is that the associations previously
found between fragmented sleep and reduction in concentration of melatonin is largely
due to environment influences, such as light at night, or postpartum hormonal changes.
The second is that multiple nights of sleep fragmentation are necessary in order to
observe the physiological changes in melatonin. It is likely that a combination of these
factors account for some of the suppression of melatonin found among sleep
fragmented populations.
There are only a couple of studies that have examined how sleep patterns
change during the postpartum period, and findings are inconclusive. The lack of existing
evidence is likely due to the difficulties in the longitudinal data collection from prepregnancy, pregnancy, and the postpartum period that would adequately address this
question; such a longitudinal study has never been done. Wolfson, Crowley, Anwer, &
Bassett (2003) show no changes in bedtime, but later rise times by an average of 52
minutes between the end of pregnancy and 2-4 weeks postpartum. This supports the
current study’s protocol of keeping bedtimes constant, but extending rise times.
Recently, using a small sample (n=12) of women who had a history of major depression
disorder, Sharkey, Pearlstein, & Carskadon (2013) characterized changes in circadian
phase from the third trimester of pregnancy to the 6th postpartum week. There was an
average phase delay of 42 minutes from pregnancy to postpartum; six women had
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phase delays >1 hour. However, there were no changes in actigraphically-recorded
bedtimes and wake times, in contrast to the findings of Wolfson and colleagues. Further
research in the change of sleep periods and circadian phase during the postpartum
period is warranted.
Sleep Architecture
The current study’s sleep fragmentation protocol resulted in no changes in any of
the nocturnal sleep stages. This finding counters the literature on experimental sleep
fragmentation among healthy subjects. Previous studies have reliably demonstrated
sleep fragmentation increases in stage N1 and decreases in stage N3 and/or REM
(Bonnet, 1985; Roehrs et al.,1994). However, these studies have used sleep
fragmentation protocols that simulate sleep-fragmenting disorders such as obstructive
sleep apnea. In these protocols, participants are awakened every couple of minutes for
only brief moments of time, throughout the entire night. At the time of the proposal, the
current study was the first that was known to experimentally simulate longer periods of
consolidated sleep, with longer periods of wake. However, recently one other group
created a sleep fragmentation protocol that allowed for longer periods of consolidated
sleep. Gonnissen et al. (2013) interrupted the sleep of healthy males about every 90
minutes throughout the night (5 awakenings in total). However, the awakenings were
brief; as long as it took participants to turn off an alarm (about 2 min). The results
showed a decrease in stage REM sleep at the expense of an increase in stage N2
sleep. This protocol was the most similar to that used in the current study, but still took
advantage of more frequent awakenings. It is possible current results did not show
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changes in time spent in stage N3 or REM sleep because there were too few
awakenings.
While working as the night technician for the sleep fragmentation night, ALM
noticed a trend in real-time of decreasing sleep onset latencies after each of the three
scheduled awakenings. This observation provided the impetus for analyzing the
supplemental data of the changes in sleep onset latencies from each awakening across
the night. The statistical analyses supported this observation, indicating subjects have a
higher sleep propensity after each progressive awakening. This effect of time of night on
sleep propensity has been previously reported in sleep fragmentation protocols where
participants were awakened every two hours (Helmus et al., 1996; Nykamp et al.,
1999). Furthermore, in their seminal study, Dijk and Czeisler (1995) used a forced
desynchrony protocol of a 28 hour rest-activity cycle in an environment free of time cues
to study the circadian regulation of sleep propensity independent of the homeostatic
sleep drive. Sleep propensity was heightened during 2200 and 0600 hours, regardless
of when the sleep period occurred. The current findings provide further support for a
circadian modulation (Process C) of sleep propensity in the context of the two-process
model of sleep regulation. As the latency to sleep onset was at a time of night when the
most hours of sleep were accrued, it is not reasonable to assume that only the
homeostatic sleep drive (Process S: the regulation of sleep propensity on the basis of
prior wake time) regulates sleep propensity. The interaction between the two processes,
the circadian timing and homeostatic sleep drive, explains the consolidated nocturnal
sleep period. The homeostatic sleep drive is prominent in the first few hours of nocturnal
sleep, weakening across the night as more sleep is accrued, at which point the
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circadian sleep drive predominantly takes over, allowing sleep to continue (Dijk & von
Schantz, 2005).
Daytime Sleepiness
Results did not support an increase in objective daytime sleepiness after sleep
fragmentation. Conversely, women had a decrease in daytime sleepiness, and while
this decrease was not significant, it was supported by a large effect size (Cohen’s
d=0.92). However, both the average baseline and post-fragmentation MSLT scores
were >10, a score that is considered normative among a healthy population (Afifi et al.,
2005). So while the scores non-significantly increased, the meaningfulness of the
change in scores from a clinical perspective in diagnosing daytime sleepiness is
negligible.
The result of no difference in objective sleepiness before and after sleep
fragmentation was unexpected when taken in the context of the literature on the impact
of sleep fragmentation with daytime sleepiness. Sleep disorders that are characterized
by sleep fragmentation cause daytime sleepiness (Benbadis, 2005). Furthermore,
experimental sleep fragmentation among healthy populations in a study design that
carefully extended sleep periods in accordance with increased nocturnal wakefulness to
ensure total sleep time did not differ, caused significantly decreased MSLT scores by
4.5 mins after a single night of fragmentation (Roehrs, 1994). However, this study
fragmented sleep with an auditory tone every 2 minutes, a procedure that altered sleep
architecture; participants spent significantly more time in the lighter stages of sleep
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(stages N1 and N2) and less time in stage N3 and REM sleep. This change in sleep
architecture is something the current procedure did not achieve.
One potential explanation for the inconsistency between current results and
previous literature of the impact of sleep fragmentation on daytime sleepiness is there
were no changes in stage N3 sleep in the current study. The reduction in percentage of
the sleep period spent in stage N3 in previous studies may explain the associated
increase in daytime sleepiness in the aforementioned studies. There were no changes
in total sleep time, but decreases in stage N3 sleep and MSLT scores when sleep was
experimentally fragmented to cause a transient increase in blood pressure or heart rate
but no visible EEG arousal (Martin, Wraith, Deary, & Douglas, 1997). When gaboxadol,
a stage N3-enhancing drug, was administered prior to each night of a 4-night sleep
restriction protocol (5 hours of sleep each night), total sleep time did not differ between
the placebo and gaboxadol groups, but stage N3 was significantly enhanced in the
gaboxadol group on each night. While both placebo and gaboxadol groups had
decreased MSLT scores from baseline to after the 4-night sleep restriction protocol, the
decrease was significantly less for the gaboxadol compared to placebo (Walsh et al.,
2008). Taken in context, given the current findings of minimal changes in sleep
architecture, it is likely not surprising there were no effects on MSLT scores.
However, there is also support for the idea that the effect of sleep fragmentation
on daytime sleepiness is mediated by the disturbance of sleep continuity as opposed to
changes in sleep stages. The results of a clustered experimental sleep fragmentation
(disturbances every 30 sec for 30 min, followed by 60 min uninterrupted sleep) protocol
indicated greater portions of time spent in stage N3 sleep compared to subjects whose
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sleep was fragmented every 90 sec throughout the night. However, there were no
differences in MSLT scores between the clustered or regular sleep fragmentation,
despite the differences in sleep architecture (Martin, Brander, Deary, & Douglas, 1999).
Similarly, another study used a sleep fragmentation protocol in which participants’ sleep
was fragmented for two nights approximately 70 times each night. Results showed no
difference in sleep architecture between the baseline and experimental nights, however,
there was a significant decrease in MSLT scores (Stepanski, Lamphere, Roehrs, Zorick,
& Roth, 1987). Interpretation of the current results lend support to either the importance
of alterations to sleep stages in causing daytime sleepiness or the necessity of more
frequent nocturnal awakenings to cause sufficient interruption of sleep continuity to
reduce daytime sleepiness.
After spending 3 consecutive nights in the laboratory, the post-fragmentation
MSLT was the final laboratory-based procedure in the protocol. It cannot be discounted
that participants may have been less likely to fall asleep because they were excited they
were nearing the end of the study. On the fourth and final nap of the post-fragmentation
MSLT, 81.8% of participants did not fall asleep. This compares to 27.3% who did not fall
asleep on the final nap of the baseline MSLT. While this likely does not explain the lack
of decrease in MSLT scores as a result of sleep fragmentation, it may explain the
significant increase in MSLT scores after sleep fragmentation.
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Post-Fragmentation Week
Total Sleep Time
Contrary to the hypothesis, nocturnal total sleep time monitored for one week
post-sleep fragmentation showed no difference in total sleep time the night immediately
after sleep fragmentation compared to baseline. There was also no change in total
sleep time across the post-fragmentation week. Supplemental data analysis on naps
found no statistically significant difference in naps between baseline and recovery
weeks, and the majority of the naps taken occurred the day after the first recovery night
from sleep fragmentation. It’s possible that the lack of change in sleep stems from the
participants’ instructions to sleep ad libitum during the recovery week, compared to the
consistent sleep schedule with at least 8 hours in spent in bed each night attempting to
sleep during baseline. This was not required during the recovery week, so it is unknown
whether participants merely did not physiologically need to extend their sleep after sleep
fragmentation, or they chose not to extend their sleep (for potentially social or work
reasons).
Performance
Neurocognitive performance, assessed each morning of the study protocol,
showed a significant difference from pre- to post-fragmentation, lending support to the
hypothesis of a decrease in neurocognitive performance after sleep fragmentation
despite no difference in total sleep time. These results provide causal evidence that
postpartum-like sleep fragmentation has a negative impact on performance independent
of total sleep time. There was no trajectory of recovery among these participants;
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statistically, the PVT values did not change across the post-fragmentation week. As
Banks et al. (2010) reported, a 10 hour time in bed protocol the night after chronic sleep
restriction was insufficient to return performance to baseline values. If participants in the
current study did not allow for enough time devoted to sleep after the sleep
fragmentation night, their performance data may be a reflection of a buildup of sleep
debt that has not been adequately repaid.
Supplemental analyses compared performance of the current sample of
nulliparous women with primiparous women in the second postpartum week and found
postpartum women had significantly worse performance than nulliparous women. This
difference is most likely an effect of the impact of cumulative sleep disturbance on
performance among postpartum women (Insana, Williams, & Montgomery-Downs,
2013), as the postpartum women were already in their second postpartum week.
Furthermore, women experience sleep disturbances during the third trimester (Wilson et
al., 2011; Wolfson et al., 2003), which means they are already entering the postpartum
period with sleep debt, as opposed to the current sample who were well rested prior to
their sleep fragmentation night.
Mood
Results indicate that mood, as scored through the POMS total mood disturbance,
worsens after experimental sleep fragmentation. At baseline, participants had an
average score of -1.00 (lower scores are indicative of better mood), which rose to an
average of 8.55 across the post-fragmentation week. Supplemental analyses comparing
these data to POMS scores of healthy postpartum women 2 weeks after birth found no
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significant difference between groups. However, the p-value was approaching
significance and there was a moderate effect size (Cohen’s d=0.66) trending towards
postpartum women reporting worse mood. Yet, these differences may not be a function
of differences between postpartum women and non-postpartum controls, as another
validation study of the POMS on a healthy population of 208 adult women found
averages POMS scores of 20.3 (SD=33.1) (Nyenhuis, Yamamoto, Luchetta, Terrien, &
Parmentier, 1999).
The substantially lower baseline mood scores of the women in the current study
compared to the healthy sample may be an effect of age; in the Nyenhuis et al. (1999)
study, the women were on average 44 years (range 18-94) compared to the current
study’s 25 years (range 23-30). Previous literature using the POMS to measure mood
report age-related declines in mood states (Gibson, 1997). Alternatively (or additionally),
the lower baseline scores may be an effect of sleep, as chronic sleep restriction can
cause mood disturbances (Dinges et al., 1997). The women in the current sample were
screened to be healthy sleepers, and they averaged 7 hours 41minutes of total sleep
time during baseline, approximately 20 minutes more than that obtained by 25-year olds
(Ohayon, Carskadon, Guilleminault, & Vitiello, 2004). They also obtained consistent
sleep periods during the baseline week, another aspect of sleep that has been found to
improve mood (Takasu, Takenaka, Fujiwara, & Toichi, 2012).
The supplemental analyses suggest it may not be the obvious dimensions of
mood (e.g. depression, anxiety) that are impacted. When subscales were analyzed,
there were significant changes in fatigue (increased) and vigor (decreased) postfragmentation. However, no significant changes were noted in tension, depression,
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anxiety, or confusion. This is consistent with previous work that found chronic sleep
restriction impacts POMS total mood disturbance scores, and specifically subscales of
fatigue, vigor, confusion, and tension (Dinges et al., 1997). However, it is inconsistent
with the postpartum depression literature; based on the occurrence of postpartum
depression, there would be an expected increase in the depression subscale after one
night of sleep fragmentation. As this was not the case, it is speculated the relation
between sleep and postpartum depression is a result of the longer-term sleep
fragmentation postpartum women experience (that was not modeled in the current
study), potentially combined with sleep quality during pregnancy (Wilson et al., 2011;
Wolfson et al., 2003). Environmental factors, such as low levels of social support or a
recent stressful event (Robertson et al., 2004) or changes in concentrations of sex
steroids after parturition (Russell et al., 2000) may also be contributing factors of
postpartum mood disturbances and warrant further research.
Limitations
The study had a number of limitations, including the small sample size. Although
the sample size was consistent with previous literature that have similar experimental
sleep fragmentation protocols, it limited analyzing whether individuals who did have
changes in dependent variables from baseline to sleep fragmentation nights differed
from those who did not have changes in dependent variables on demographic
measures, for instance. Individual differences such as these may give insight into why
some women were more affected by the sleep fragmentation protocol than others.
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Another limitation may have been the rigorous selection criteria. While these
criteria were put in place to reducing confounding factors on the outcome variables of
interest, there were a large proportion of women who were excluded from continued
participation because they did not meet minimum scores on the MSLT (n=4). However,
their baseline actigraphy sleep appeared healthy. Participants who were more resistant
to the effects of sleep disturbances may have been unintentionally selected. Those who
were excluded may be more sensitive to the effects of sleep disturbances, and may
have been impacted more by the sleep fragmentation.
Finally, the awakenings may not have been long enough to model the early
postpartum period. While the protocol followed the available literature in guiding the
number and duration of awakenings, recent unpublished findings from our lab found
mothers with very young infants (<1 month) self-reported an average of 3.6 awakenings
each night, and each awakening was an average duration of 55 minutes. This is over 20
minutes longer than the protocol used in the current study. These unpublished data also
found that as the infant ages, the duration of the awakenings shortens. However, it
supports early postpartum longer nocturnal awakenings.
Future Directions
Future research should expand upon this sleep fragmentation protocol to
determine what factors may contribute to the impairment that was generally not seen in
this study. Some additions to the protocol could include multiple nights of sleep
fragmentation in an attempt to assess the effects of a chronic postpartum sleep
fragmentation as opposed to an acute focus.
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Furthermore, variations in nocturnal activities and lighting levels could be
assessed to determine their impact on physiological measures and performance
outcomes. The current protocol carefully kept subjects out of light levels that could
disrupt their melatonin levels and the focus of the awakenings was solely on infant
caregiving. This was in order to isolate the impact of the sleep fragmentation. Future
studies should work to understand how the differences in activities and behaviors
postpartum women engage in may be negatively impacting their sleep. Unpublished
data from our lab indicate 81.5% of women reported using an electronic device
(television, computer, cell phone, backlit tablet, or a combination of these) during
nocturnal awakenings and 89% of women are using at least one extra light source
during caregiving, but their light sources vary widely in intensity. Examining the impact
of these behaviors, both in field-based and laboratory settings, are important next steps
to understanding maternal sleep disturbances.
Finally, more research should be directed towards the impact of postpartum
changes in physiology on sleep and circadian rhythms. Early evidence suggests
hormonal changes in postpartum women may be contributing to changes in circadian
rhythms and sleep architecture. Feeding method may be moderating some of the
hormonal changes, as breast-feeding promotes the release of prolactin, a hormone
strongly associated with sleep. However, much of the impact of postpartum
physiological changes on sleep remains unclear.
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Conclusion
A complex process of physiological and environmental changes during the
postpartum period confounds our understanding of the discrete impacts of postpartum
sleep fragmentation. The present study sought to isolate the effects of postpartum sleep
fragmentation on sleep architecture, nocturnal melatonin, mood, daytime sleepiness,
performance, and recovery by manipulating the sleep of childless women in the
laboratory to model postpartum sleep fragmentation. The postpartum reduction in sleep
efficiency with no change to total sleep time was successfully modeled. No differences
were found in nocturnal melatonin concentration or time spent in sleep stages between
baseline and sleep fragmentation nights. A significant decrease in daytime sleepiness
after fragmentation compared to baseline was observed, specifically on the fourth and
final MSLT nap opportunity. There was no change in total sleep time the night after
sleep fragmentation. Sleep fragmentation did cause performance and mood decrements
across the week post-sleep fragmentation compared to baseline. Results suggest no
physiological changes of a single night of simulated postpartum sleep fragmentation,
but significant deficits in mood and neurobehavioral performance. These findings
suggest that the mere disruption of sleep continuity in the absence of the measured
physiological changes is sufficient to cause poorer mood and performance, stressing
the importance of examining both subjective and objective measures in sleep
fragmented populations.
This study expands the literature by providing a basic understanding of the acute
effects of postpartum sleep fragmentation. It was also the first to model this sleep
disturbance using childless women, establishing the feasibility of using childless women
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in future studies to assess chronic sleep fragmentation or alterations in the nocturnal
environment, such as the impact of light and electronic use at night.
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APPENDIX A.
Sleep Disorders Screening Chart
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Center for Epidemiologic Studies Depression Scale (CES-D)
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Rules for revisions of MSLT scores

Original MSLT score & HMD retrospective score
Rules for:
Total MSLT
Score

MSLT score differed by ≤1
min (n=15)

MSLT score differed by >1
min (n=13; corresponds to 52
naps)

Retained original score

ALM administered nap
(n=12 naps)

Retained original score

Rules for:
Individual
Nap
Opportunities

A research assistant
administered the nap (n=40
naps)
A research assistant &
HMD retrospective
scores were in 100%
agreement (n=19 naps)

Retained original score

3-way disagreement
between original, HMD,
and ALM retrospective
scores (n=9 naps)

Retained original score

A research assistant
administered the nap (n=21
naps)

HMD and ALM
retrospective scores were
in 100% agreement (n=12
naps)

Original score changed to
retrospective score
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MCBEAN’S SPAGHETTI SAUCE
2¼ lbs lean ground beef
2 cans (10 oz.) tomato soup
1 can (14 oz.) Hunt’s tomato sauce
2 Tbsps. Lea & Perrins Worcestershire sauce
3-5 drops Tobasco sauce
½ tsp. black pepper
2 tsp. oregano
1 tsp. onion salt
3 cloves garlic, pressed
4 oz. button mushrooms, minimum
3 Tbsps. extra virgin olive oil
1.

In a large frying pan, brown the lean ground beef (at medium to medium high)
until there are next to no juices on the bottom of the frying pan.

2.

Combine the tomato soup, the tomato sauce, the Worcestershire sauce, the
Tobasco sauce, pepper, oregano, onion salt and garlic into the browned beef.

3.

In a separate smaller frying pan, and usually at the same time or slightly behind
the browning of the lean ground beef, sauté the mushrooms (over low heat) in
the olive oil. Just brown the mushrooms, do not overcook! Add the mushrooms
to the sauce, when ready.

4.

Simmer for about 1 hour. If you want to simmer longer, add small quantities of
water when necessary.

Makes 8 servings.

